positionForPages[381]={page:381,positions:[{w:"Trust the ",p:[0.080559,0.345515,0.240615,0.345515,0.240615,0.305785,0.080559,0.305785,-0.017998,-0.013639,-0.021466,-0.018841,-0.011905,-0.011014,-0.011905,-0.021466,-0.020575,-0.011249]},{w:"science behind",p:[0.240381,0.345932,0.517563,0.345932,0.517563,0.304778,0.240381,0.304778,-0.020575,-0.021466,-0.011014,-0.021466,-0.023200,-0.021466,-0.021466,-0.011014,-0.023200,-0.021466,-0.023200,-0.011014,-0.023200,-0.023434]},{w:" the original etoricoxib…",p:[0.517329,0.345515,0.942804,0.345515,0.942804,0.305785,0.517329,0.305785,-0.011014,-0.011905,-0.021466,-0.020575,-0.011014,-0.020575,-0.013639,-0.009327,-0.021466,-0.009327,-0.021466,-0.020575,-0.009327,-0.011014,-0.020575,-0.011905,-0.020575,-0.013639,-0.009327,-0.019732,-0.020575,-0.018794,-0.009327,-0.021466,-0.046869]},{w:"Ex",p:[0.587471,0.675100,0.627383,0.675100,0.627383,0.640070,0.587471,0.640070,-0.020343,-0.019570]},{w:"cellence",p:[0.627383,0.675100,0.767504,0.675100,0.767504,0.640070,0.627383,0.640070,-0.019570,-0.019570,-0.010578,-0.010578,-0.019570,-0.021116,-0.019570,-0.019570]},{w:" in Efficacy",p:[0.767500,0.674577,0.937465,0.674577,0.937465,0.641320,0.767500,0.641320,-0.009964,-0.008469,-0.019222,-0.009964,-0.019222,-0.012413,-0.012413,-0.008469,-0.017686,-0.018433,-0.016855,-0.016855]},{w:"1-10",p:[0.940658,0.659259,0.965854,0.659259,0.965854,0.647996,0.940658,0.647996,-0.006749,-0.004949,-0.006749,-0.006749]},{w:"1,2",p:[0.917672,0.324675,0.938580,0.324675,0.938580,0.310718,0.917672,0.310718,-0.008363,-0.004182,-0.008363]},{w:"APPROVED FOR A BROAD RANGE OF INDICATIONS",p:[0.164595,0.745362,0.854277,0.745362,0.854277,0.716488,0.164595,0.716488,-0.019314,-0.018662,-0.018662,-0.019932,-0.019314,-0.018079,-0.017393,-0.019932,-0.009160,-0.016741,-0.019314,-0.019932,-0.007890,-0.019314,-0.009160,-0.019932,-0.019932,-0.019314,-0.019314,-0.019932,-0.009160,-0.019932,-0.019314,-0.020549,-0.019314,-0.017393,-0.009160,-0.019314,-0.016741,-0.009160,-0.009160,-0.020549,-0.019932,-0.009160,-0.018662,-0.017427,-0.016089,-0.009160,-0.019314,-0.020549,-0.018422]},{w:"IN PATIENTS ≥ 16 YEARS OF AGE",p:[0.363785,0.763706,0.645288,0.763706,0.645288,0.745016,0.363785,0.745016,-0.004760,-0.012973,-0.005600,-0.010360,-0.010383,-0.010803,-0.004760,-0.010803,-0.012973,-0.010803,-0.011666,-0.005600,-0.011596,-0.005600,-0.011200,-0.011200,-0.004736,-0.010779,-0.010803,-0.011666,-0.012109,-0.011666,-0.005600,-0.012973,-0.010360,-0.004736,-0.011666,-0.012529,-0.010803]},{w:" 2",p:[0.645286,0.756821,0.655080,0.756821,0.655080,0.745925,0.645286,0.745925,-0.003265,-0.006529]},{w:"SELECTED SAFETY INFORMATION: ",p:[0.080772,0.832719,0.185386,0.832719,0.185386,0.825644,0.080772,0.825644,-0.003972,-0.003699,-0.003425,-0.003699,-0.003972,-0.003418,-0.003699,-0.004246,-0.003469,-0.003972,-0.004113,-0.003558,-0.003699,-0.003418,-0.003847,-0.003469,-0.001923,-0.004379,-0.003558,-0.004113,-0.004246,-0.005607,-0.003706,-0.003418,-0.001923,-0.004113,-0.004379,-0.001650,-0.001923]},{w:"CONTRAINDICATIONS:",p:[0.186940,0.832684,0.250336,0.832684,0.250336,0.825709,0.186940,0.825709,-0.003972,-0.004113,-0.004246,-0.003551,-0.004113,-0.004113,-0.001909,-0.004246,-0.004246,-0.001909,-0.003839,-0.003706,-0.003551,-0.001909,-0.004113,-0.004246,-0.003839,-0.001775]},{w:" EXINEF is contraindicated in: patients with known hypersensitivity to any of the excipients of EXINEF; patients with active peptic ulceration or gastrointestinal (GI) bleeding; patients with severe hepatic dysfunction (Child-Pugh score > 9 ",p:[0.250336,0.832613,0.940098,0.832613,0.940098,0.825879,0.250336,0.825879,-0.003203,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.003203,-0.001509,-0.003011,-0.003203,-0.003151,-0.003285,-0.003425,-0.001916,-0.002190,-0.003285,-0.001509,-0.003425,-0.003425,-0.001509,-0.003151,-0.003358,-0.001916,-0.003285,-0.003425,-0.003203,-0.001509,-0.003425,-0.001502,-0.003203,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.003203,-0.004794,-0.001509,-0.001916,-0.003425,-0.003203,-0.003285,-0.003425,-0.003358,-0.004794,-0.003425,-0.003203,-0.003425,-0.003003,-0.003425,-0.003285,-0.002190,-0.003011,-0.003285,-0.003425,-0.003011,-0.001509,-0.001916,-0.001509,-0.003003,-0.001509,-0.001916,-0.003003,-0.003203,-0.001916,-0.003285,-0.003203,-0.003285,-0.003499,-0.003003,-0.003203,-0.003285,-0.001916,-0.003203,-0.001916,-0.003425,-0.003285,-0.003203,-0.003285,-0.003003,-0.003151,-0.001509,-0.003425,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.003203,-0.003285,-0.001916,-0.003203,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.001775,-0.003203,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.003203,-0.004794,-0.001509,-0.001916,-0.003425,-0.003203,-0.003285,-0.003151,-0.001916,-0.001509,-0.003003,-0.003285,-0.003203,-0.003425,-0.003322,-0.003425,-0.001916,-0.001509,-0.003151,-0.003203,-0.003425,-0.001509,-0.003151,-0.003285,-0.002190,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.003203,-0.003285,-0.002190,-0.003203,-0.003425,-0.003285,-0.003011,-0.001916,-0.002190,-0.003285,-0.001509,-0.003425,-0.001916,-0.003285,-0.003011,-0.001916,-0.001509,-0.003425,-0.003285,-0.001509,-0.003203,-0.001783,-0.003972,-0.001509,-0.001783,-0.003203,-0.003425,-0.001509,-0.003285,-0.003285,-0.003425,-0.001509,-0.003425,-0.003425,-0.001775,-0.003203,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.003203,-0.004794,-0.001509,-0.001916,-0.003425,-0.003203,-0.003011,-0.003285,-0.003003,-0.003285,-0.002190,-0.003285,-0.003203,-0.003425,-0.003285,-0.003425,-0.003358,-0.001916,-0.001509,-0.003151,-0.003203,-0.003499,-0.003003,-0.003011,-0.001916,-0.003425,-0.003425,-0.003151,-0.001916,-0.001509,-0.003285,-0.003425,-0.003203,-0.001783,-0.003839,-0.003425,-0.001509,-0.001509,-0.003425,-0.002604,-0.003558,-0.003425,-0.003425,-0.003425,-0.003203,-0.003011,-0.003151,-0.003285,-0.002190,-0.003285,-0.003203,-0.004438,-0.003203,-0.003551,-0.001775]},{w:"or serum albumin < 25 g/l); patients with estimated creatinine clearance < 30 ml/min; patients who have developed signs of asthma, acute rhinitis, nasal polyps, angioedema or urticaria following the administration of aspirin or other non-steroidal anti-inﬂ  ammatory drugs (NSAIDs) including EXINEF; ",p:[0.080772,0.839530,0.940103,0.839530,0.940103,0.832796,0.080772,0.832796,-0.003285,-0.002190,-0.002818,-0.003011,-0.003285,-0.002190,-0.003425,-0.005341,-0.002818,-0.003285,-0.001509,-0.003425,-0.003425,-0.005341,-0.001509,-0.003425,-0.002818,-0.004438,-0.002818,-0.003551,-0.003551,-0.002818,-0.003425,-0.002057,-0.001509,-0.001783,-0.001775,-0.002818,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.002818,-0.004794,-0.001509,-0.001916,-0.003425,-0.002818,-0.003285,-0.003011,-0.001916,-0.001509,-0.005341,-0.003358,-0.001916,-0.003285,-0.003425,-0.002818,-0.003151,-0.002190,-0.003285,-0.003358,-0.001916,-0.001509,-0.003425,-0.001509,-0.003425,-0.003285,-0.002818,-0.003003,-0.001509,-0.003285,-0.003285,-0.002190,-0.003285,-0.003425,-0.003151,-0.003285,-0.002818,-0.004438,-0.002818,-0.003551,-0.003551,-0.002818,-0.005341,-0.001509,-0.002057,-0.005341,-0.001509,-0.003425,-0.001775,-0.002818,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.002818,-0.004794,-0.003425,-0.003285,-0.002818,-0.003425,-0.003358,-0.003003,-0.003285,-0.002818,-0.003425,-0.003285,-0.003003,-0.003285,-0.001509,-0.003285,-0.003425,-0.003285,-0.003425,-0.002818,-0.003011,-0.001509,-0.003425,-0.003425,-0.003011,-0.002818,-0.003285,-0.001916,-0.002818,-0.003285,-0.003011,-0.001916,-0.003425,-0.005341,-0.003285,-0.001502,-0.002818,-0.003285,-0.003151,-0.003425,-0.001916,-0.003285,-0.002818,-0.002190,-0.003425,-0.001509,-0.003425,-0.001509,-0.001916,-0.001509,-0.003011,-0.001502,-0.002818,-0.003425,-0.003285,-0.003011,-0.003285,-0.001509,-0.002818,-0.003425,-0.003285,-0.001509,-0.003003,-0.003425,-0.003011,-0.001502,-0.002818,-0.003285,-0.003425,-0.003425,-0.001509,-0.003285,-0.003285,-0.003425,-0.003285,-0.005341,-0.003285,-0.002818,-0.003285,-0.002190,-0.002818,-0.003425,-0.002190,-0.001916,-0.001509,-0.003151,-0.003285,-0.002190,-0.001509,-0.003285,-0.002818,-0.001916,-0.003285,-0.001509,-0.001509,-0.003358,-0.004794,-0.001509,-0.003425,-0.003425,-0.002818,-0.001916,-0.003425,-0.003285,-0.002818,-0.003285,-0.003425,-0.005341,-0.001509,-0.003425,-0.001509,-0.003011,-0.001916,-0.002190,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.002818,-0.003285,-0.001916,-0.002818,-0.003285,-0.003011,-0.003425,-0.001509,-0.002190,-0.001509,-0.003425,-0.002818,-0.003285,-0.002190,-0.002818,-0.003285,-0.001916,-0.003425,-0.003285,-0.002190,-0.002818,-0.003425,-0.003285,-0.003425,-0.002604,-0.003011,-0.001916,-0.003285,-0.002190,-0.003285,-0.001509,-0.003425,-0.003285,-0.001509,-0.002818,-0.003285,-0.003425,-0.001916,-0.001509,-0.002604,-0.001589,-0.003425,-0.003425,0.001716,-0.001709,-0.003285,-0.005341,-0.005341,-0.003358,-0.001916,-0.003285,-0.002323,-0.003003,-0.002818,-0.003425,-0.002190,-0.003425,-0.003425,-0.003011,-0.002818,-0.001783,-0.004113,-0.003699,-0.003699,-0.001509,-0.004113,-0.003011,-0.001783,-0.002818,-0.001509,-0.003425,-0.003003,-0.001509,-0.003425,-0.003425,-0.001509,-0.003425,-0.003425,-0.002818,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.001775,-0.001775]},{w:"hypertension which has not been adequately controlled; pregnancy and lactation; children and adolescents under 16 years of age; patients with inﬂ  ammatory bowel disease; patients with congestive heart failure (NYHA II - IV); established ischaemic heart disease, peripheral arterial disease and/or ",p:[0.080772,0.846446,0.940142,0.846446,0.940142,0.839712,0.080772,0.839712,-0.003425,-0.003003,-0.003425,-0.003285,-0.002190,-0.001916,-0.003285,-0.003425,-0.003011,-0.001509,-0.003285,-0.003425,-0.003040,-0.004794,-0.003425,-0.001509,-0.003151,-0.003425,-0.003040,-0.003425,-0.003285,-0.003011,-0.003040,-0.003425,-0.003285,-0.001916,-0.003040,-0.003425,-0.003285,-0.003285,-0.003425,-0.003040,-0.003285,-0.003425,-0.003285,-0.003425,-0.003425,-0.003358,-0.001916,-0.003285,-0.001509,-0.003003,-0.003040,-0.003151,-0.003285,-0.003425,-0.001916,-0.002190,-0.003285,-0.001509,-0.001509,-0.003285,-0.003425,-0.001775,-0.003040,-0.003425,-0.002190,-0.003285,-0.003425,-0.003425,-0.003285,-0.003425,-0.003003,-0.003003,-0.003040,-0.003285,-0.003425,-0.003425,-0.003040,-0.001509,-0.003285,-0.003151,-0.001916,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001775,-0.003040,-0.003151,-0.003425,-0.001509,-0.001509,-0.003425,-0.002190,-0.003285,-0.003425,-0.003040,-0.003285,-0.003425,-0.003425,-0.003040,-0.003285,-0.003425,-0.003285,-0.001509,-0.003285,-0.003011,-0.003151,-0.003285,-0.003425,-0.001916,-0.003011,-0.003040,-0.003425,-0.003425,-0.003425,-0.003285,-0.002190,-0.003040,-0.003551,-0.003551,-0.003040,-0.003003,-0.003285,-0.003285,-0.002190,-0.003011,-0.003040,-0.003285,-0.001916,-0.003040,-0.003358,-0.003425,-0.003285,-0.001775,-0.003040,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.003040,-0.004794,-0.001509,-0.001916,-0.003425,-0.003040,-0.001509,-0.003425,-0.003425,0.001716,-0.001709,-0.003285,-0.005341,-0.005341,-0.003358,-0.001916,-0.003285,-0.002323,-0.003003,-0.003040,-0.003425,-0.003358,-0.004794,-0.003285,-0.001509,-0.003040,-0.003425,-0.001509,-0.003011,-0.003285,-0.003285,-0.003011,-0.003285,-0.001775,-0.003040,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.003040,-0.004794,-0.001509,-0.001916,-0.003425,-0.003040,-0.003151,-0.003285,-0.003425,-0.003425,-0.003285,-0.003011,-0.001916,-0.001509,-0.003003,-0.003285,-0.003040,-0.003425,-0.003285,-0.003285,-0.002190,-0.001916,-0.003040,-0.001916,-0.003285,-0.001509,-0.001509,-0.003425,-0.002190,-0.003285,-0.003040,-0.001783,-0.004113,-0.003418,-0.003972,-0.003699,-0.003040,-0.001509,-0.001509,-0.003040,-0.002604,-0.003040,-0.001509,-0.003418,-0.001783,-0.001775,-0.003040,-0.003285,-0.003011,-0.001916,-0.003285,-0.003425,-0.001509,-0.001509,-0.003011,-0.003425,-0.003285,-0.003425,-0.003040,-0.001509,-0.003011,-0.003151,-0.003425,-0.003285,-0.003285,-0.005341,-0.001509,-0.003151,-0.003040,-0.003425,-0.003285,-0.003285,-0.002190,-0.001916,-0.003040,-0.003425,-0.001509,-0.003011,-0.003285,-0.003285,-0.003011,-0.003285,-0.001502,-0.003040,-0.003425,-0.003285,-0.002190,-0.001509,-0.003425,-0.003425,-0.003285,-0.002190,-0.003285,-0.001509,-0.003040,-0.003285,-0.002190,-0.001916,-0.003285,-0.002190,-0.001509,-0.003285,-0.001509,-0.003040,-0.003425,-0.001509,-0.003011,-0.003285,-0.003285,-0.003011,-0.003285,-0.003040,-0.003285,-0.003425,-0.003425,-0.002057,-0.003285,-0.002190,-0.001775]},{w:"cerebrovascular disease; perioperative analgesia in the setting of coronary artery bypass surgery (CABG). ",p:[0.080772,0.853362,0.380487,0.853362,0.380487,0.846628,0.080772,0.846628,-0.003151,-0.003285,-0.002190,-0.003285,-0.003425,-0.002190,-0.003285,-0.003003,-0.003285,-0.003011,-0.003151,-0.003425,-0.001509,-0.003285,-0.002190,-0.002715,-0.003425,-0.001509,-0.003011,-0.003285,-0.003285,-0.003011,-0.003285,-0.001775,-0.002715,-0.003425,-0.003285,-0.002190,-0.001509,-0.003285,-0.003425,-0.003285,-0.002190,-0.003358,-0.001916,-0.001509,-0.003003,-0.003285,-0.002715,-0.003285,-0.003425,-0.003285,-0.001509,-0.003425,-0.003285,-0.003011,-0.001509,-0.003285,-0.002715,-0.001509,-0.003425,-0.002715,-0.001916,-0.003425,-0.003285,-0.002715,-0.003011,-0.003285,-0.001916,-0.001916,-0.001509,-0.003425,-0.003425,-0.002715,-0.003285,-0.001916,-0.002715,-0.003151,-0.003285,-0.002190,-0.003285,-0.003425,-0.003285,-0.002323,-0.003003,-0.002715,-0.003285,-0.002190,-0.001916,-0.003285,-0.002323,-0.003003,-0.002715,-0.003425,-0.003003,-0.003425,-0.003285,-0.003011,-0.003011,-0.002715,-0.003011,-0.003425,-0.002190,-0.003425,-0.003285,-0.002323,-0.003003,-0.002715,-0.001783,-0.003839,-0.003699,-0.003839,-0.003972,-0.001783,-0.001502,-0.001775]},{w:"WARNINGS AND SPECIAL PRECAUTIONS: ",p:[0.381419,0.853433,0.503544,0.853433,0.503544,0.846458,0.381419,0.846458,-0.005489,-0.004113,-0.004113,-0.004246,-0.001909,-0.004246,-0.004113,-0.003839,-0.002715,-0.004113,-0.004246,-0.004246,-0.002715,-0.003839,-0.003839,-0.003558,-0.003972,-0.001909,-0.004113,-0.003425,-0.002715,-0.003839,-0.004113,-0.003558,-0.003839,-0.004113,-0.003980,-0.003551,-0.001909,-0.004113,-0.004246,-0.003839,-0.001775,-0.001775]},{w:"EXINEF may predispose to cardiovascular events, gastrointestinal events or cutaneous reactions which may be fatal. Long-term administration of NSAIDs ",p:[0.504483,0.853362,0.940135,0.853362,0.940135,0.846628,0.504483,0.846628,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.002715,-0.005341,-0.003285,-0.003003,-0.002715,-0.003425,-0.002190,-0.003285,-0.003425,-0.001509,-0.003011,-0.003425,-0.003285,-0.003011,-0.003285,-0.002715,-0.001916,-0.003285,-0.002715,-0.003151,-0.003285,-0.002190,-0.003425,-0.001509,-0.003285,-0.003003,-0.003285,-0.003011,-0.003151,-0.003425,-0.001509,-0.003285,-0.002190,-0.002715,-0.003285,-0.003003,-0.003285,-0.003425,-0.001916,-0.003011,-0.001502,-0.002715,-0.003425,-0.003285,-0.003011,-0.001916,-0.002190,-0.003285,-0.001509,-0.003425,-0.001916,-0.003285,-0.003011,-0.001916,-0.001509,-0.003425,-0.003285,-0.001509,-0.002715,-0.003285,-0.003003,-0.003285,-0.003425,-0.001916,-0.003011,-0.002715,-0.003285,-0.002190,-0.002715,-0.003151,-0.003425,-0.001916,-0.003285,-0.003425,-0.003285,-0.003285,-0.003425,-0.003011,-0.002715,-0.002190,-0.003285,-0.003285,-0.003151,-0.001916,-0.001509,-0.003285,-0.003425,-0.003011,-0.002715,-0.004794,-0.003425,-0.001509,-0.003151,-0.003425,-0.002715,-0.005341,-0.003285,-0.003003,-0.002715,-0.003425,-0.003285,-0.002715,-0.001916,-0.003358,-0.001916,-0.003285,-0.001509,-0.001502,-0.002715,-0.003285,-0.003285,-0.003425,-0.003425,-0.002604,-0.001916,-0.003285,-0.002190,-0.005341,-0.002715,-0.003285,-0.003425,-0.005341,-0.001509,-0.003425,-0.001509,-0.003011,-0.001916,-0.002190,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.002715,-0.003285,-0.001916,-0.002715,-0.004113,-0.003699,-0.003699,-0.001509,-0.004113,-0.003011,-0.001775]},{w:"such as EXINEF has resulted in renal papillary necrosis and other renal injury. Under conditions of compromised renal perfusion, administration of EXINEF may cause a reduction in prostaglandin formation and, secondarily, in renal blood ﬂ  ow and thereby impair renal function. Caution should be used ",p:[0.080772,0.860279,0.940126,0.860279,0.940126,0.853545,0.080772,0.853545,-0.003011,-0.003425,-0.003151,-0.003425,-0.002781,-0.003285,-0.003011,-0.002781,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.002781,-0.003425,-0.003285,-0.003011,-0.002781,-0.002190,-0.003285,-0.003011,-0.003425,-0.001509,-0.001916,-0.003285,-0.003425,-0.002781,-0.001509,-0.003425,-0.002781,-0.002190,-0.003285,-0.003425,-0.003285,-0.001509,-0.002781,-0.003425,-0.003358,-0.003425,-0.001509,-0.001509,-0.001509,-0.003285,-0.002323,-0.003003,-0.002781,-0.003425,-0.003285,-0.003151,-0.002190,-0.003285,-0.003011,-0.001509,-0.003011,-0.002781,-0.003285,-0.003425,-0.003425,-0.002781,-0.003285,-0.001916,-0.003425,-0.003285,-0.002190,-0.002781,-0.002190,-0.003285,-0.003425,-0.003285,-0.001509,-0.002781,-0.001509,-0.003425,-0.001509,-0.003425,-0.002323,-0.002596,-0.001502,-0.002781,-0.003839,-0.003425,-0.003425,-0.003285,-0.002190,-0.002781,-0.003151,-0.003285,-0.003425,-0.003425,-0.001509,-0.001916,-0.001509,-0.003285,-0.003425,-0.003011,-0.002781,-0.003285,-0.001916,-0.002781,-0.003151,-0.003285,-0.005341,-0.003425,-0.002190,-0.003285,-0.005341,-0.001509,-0.003011,-0.003285,-0.003425,-0.002781,-0.002190,-0.003285,-0.003425,-0.003285,-0.001509,-0.002781,-0.003425,-0.003285,-0.002190,-0.001916,-0.003425,-0.003011,-0.001509,-0.003285,-0.003403,-0.001502,-0.002781,-0.003285,-0.003425,-0.005341,-0.001509,-0.003425,-0.001509,-0.003011,-0.001916,-0.002190,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.002781,-0.003285,-0.001916,-0.002781,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.002781,-0.005341,-0.003285,-0.003003,-0.002781,-0.003151,-0.003285,-0.003425,-0.003011,-0.003285,-0.002781,-0.003285,-0.002781,-0.002190,-0.003285,-0.003425,-0.003425,-0.003151,-0.001916,-0.001509,-0.003285,-0.003425,-0.002781,-0.001509,-0.003425,-0.002781,-0.003425,-0.002190,-0.003285,-0.003011,-0.001916,-0.003358,-0.003425,-0.001509,-0.003285,-0.003425,-0.003425,-0.001509,-0.003425,-0.002781,-0.001916,-0.003285,-0.002190,-0.005341,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.002781,-0.003285,-0.003425,-0.003425,-0.001502,-0.002781,-0.003011,-0.003285,-0.003151,-0.003285,-0.003425,-0.003425,-0.003285,-0.002190,-0.001509,-0.001509,-0.002596,-0.001502,-0.002781,-0.001509,-0.003425,-0.002781,-0.002190,-0.003285,-0.003425,-0.003285,-0.001509,-0.002781,-0.003425,-0.001509,-0.003285,-0.003285,-0.003425,-0.002781,-0.003425,0.001716,-0.001709,-0.003358,-0.004794,-0.002781,-0.003285,-0.003425,-0.003425,-0.002781,-0.001916,-0.003425,-0.003285,-0.002190,-0.003285,-0.003425,-0.003003,-0.002781,-0.001494,-0.005341,-0.003425,-0.003285,-0.001509,-0.002190,-0.002781,-0.002190,-0.003285,-0.003425,-0.003285,-0.001509,-0.002781,-0.001916,-0.003425,-0.003425,-0.003151,-0.001916,-0.001509,-0.003285,-0.003425,-0.001502,-0.002781,-0.003839,-0.003285,-0.003425,-0.001916,-0.001509,-0.003285,-0.003425,-0.002781,-0.003011,-0.003425,-0.003285,-0.003425,-0.001509,-0.003425,-0.002781,-0.003425,-0.003285,-0.002781,-0.003425,-0.003011,-0.003285,-0.003425,-0.001775]},{w:"when initiating treatment with EXINEF in patients with dehydration. Fluid retention, oedema and hypertension have been observed in patients taking EXINEF. All NSAIDs, including EXINEF, can be associated with new onset or recurrent congestive cardiac failure. Special attention should be paid to blood ",p:[0.080772,0.867195,0.940031,0.867195,0.940031,0.860461,0.080772,0.860461,-0.004794,-0.003425,-0.003285,-0.003425,-0.002678,-0.001509,-0.003425,-0.001509,-0.001916,-0.001509,-0.003358,-0.001916,-0.001509,-0.003425,-0.003425,-0.002678,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.005341,-0.003285,-0.003425,-0.001916,-0.002678,-0.004794,-0.001509,-0.001916,-0.003425,-0.002678,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.002678,-0.001509,-0.003425,-0.002678,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.002678,-0.004794,-0.001509,-0.001916,-0.003425,-0.002678,-0.003425,-0.003285,-0.003425,-0.003003,-0.003425,-0.002190,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001502,-0.002678,-0.003285,-0.001509,-0.003425,-0.001509,-0.003425,-0.002678,-0.002190,-0.003285,-0.001916,-0.003285,-0.003425,-0.001916,-0.001509,-0.003285,-0.003425,-0.001502,-0.002678,-0.003285,-0.003285,-0.003425,-0.003285,-0.005341,-0.003285,-0.002678,-0.003285,-0.003425,-0.003425,-0.002678,-0.003425,-0.003003,-0.003425,-0.003285,-0.002190,-0.001916,-0.003285,-0.003425,-0.003011,-0.001509,-0.003285,-0.003425,-0.002678,-0.003425,-0.003358,-0.003003,-0.003285,-0.002678,-0.003425,-0.003285,-0.003285,-0.003425,-0.002678,-0.003285,-0.003425,-0.003011,-0.003285,-0.002323,-0.003003,-0.003285,-0.003477,-0.002678,-0.001509,-0.003425,-0.002678,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.002678,-0.001916,-0.003285,-0.003285,-0.001509,-0.003425,-0.003425,-0.002678,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.002463,-0.001502,-0.002412,-0.003699,-0.001509,-0.001509,-0.002678,-0.004113,-0.003699,-0.003699,-0.001509,-0.004113,-0.003011,-0.001502,-0.002678,-0.001509,-0.003425,-0.003003,-0.001509,-0.003425,-0.003425,-0.001509,-0.003425,-0.003425,-0.002678,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.002463,-0.001502,-0.002678,-0.003151,-0.003285,-0.003425,-0.002678,-0.003425,-0.003285,-0.002678,-0.003285,-0.003011,-0.003011,-0.003285,-0.003151,-0.001509,-0.003358,-0.001916,-0.003285,-0.003425,-0.002678,-0.004794,-0.001509,-0.001916,-0.003425,-0.002678,-0.003425,-0.003285,-0.004794,-0.002678,-0.003285,-0.003425,-0.003011,-0.003285,-0.001916,-0.002678,-0.003285,-0.002190,-0.002678,-0.002190,-0.003285,-0.003151,-0.003425,-0.002190,-0.002190,-0.003285,-0.003425,-0.001916,-0.002678,-0.003151,-0.003285,-0.003425,-0.003425,-0.003285,-0.003011,-0.001916,-0.001509,-0.003003,-0.003285,-0.002678,-0.003151,-0.003285,-0.002190,-0.003425,-0.001509,-0.003285,-0.003151,-0.002678,-0.001916,-0.003285,-0.001509,-0.001509,-0.003425,-0.002190,-0.003285,-0.001502,-0.002678,-0.003699,-0.003425,-0.003285,-0.003151,-0.001509,-0.003285,-0.001509,-0.002678,-0.003358,-0.001916,-0.001916,-0.003285,-0.003425,-0.001916,-0.001509,-0.003285,-0.003425,-0.002678,-0.003011,-0.003425,-0.003285,-0.003425,-0.001509,-0.003425,-0.002678,-0.003425,-0.003285,-0.002678,-0.003425,-0.003285,-0.001509,-0.003425,-0.002678,-0.001916,-0.003285,-0.002678,-0.003425,-0.001509,-0.003285,-0.003285,-0.003425,-0.001775]},{w:"pressure monitoring during treatment with EXINEF. Clinical trials suggest that the selective COX-2 inhibitor class of medicines such as EXINEF are associated with an increased risk of thrombotic events (especially myocardial infarction (MI) and stroke). As the cardiovascular risks of selective COX-2 inhibitors ",p:[0.080772,0.874111,0.940143,0.874111,0.940143,0.867378,0.080772,0.867378,-0.003425,-0.002190,-0.003285,-0.003011,-0.003011,-0.003425,-0.002190,-0.003285,-0.002279,-0.005341,-0.003285,-0.003425,-0.001509,-0.001916,-0.003285,-0.002190,-0.001509,-0.003425,-0.003425,-0.002279,-0.003425,-0.003425,-0.002190,-0.001509,-0.003425,-0.003425,-0.002279,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.005341,-0.003285,-0.003425,-0.001916,-0.002279,-0.004794,-0.001509,-0.001916,-0.003425,-0.002279,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.002463,-0.001502,-0.002279,-0.003839,-0.001509,-0.001509,-0.003425,-0.001509,-0.003151,-0.003285,-0.001509,-0.002279,-0.001916,-0.002190,-0.001509,-0.003285,-0.001509,-0.003011,-0.002279,-0.003011,-0.003425,-0.003425,-0.003425,-0.003285,-0.003011,-0.001916,-0.002279,-0.001916,-0.003425,-0.003358,-0.001916,-0.002279,-0.001916,-0.003425,-0.003285,-0.002279,-0.003011,-0.003285,-0.001509,-0.003285,-0.003151,-0.001916,-0.001509,-0.003003,-0.003285,-0.002279,-0.003839,-0.003935,-0.003558,-0.002604,-0.003551,-0.002279,-0.001509,-0.003425,-0.003425,-0.001509,-0.003425,-0.001509,-0.001916,-0.003285,-0.002190,-0.002279,-0.003003,-0.001509,-0.003285,-0.003011,-0.003011,-0.002279,-0.003285,-0.001916,-0.002279,-0.005341,-0.003285,-0.003425,-0.001509,-0.003151,-0.001509,-0.003425,-0.003285,-0.003011,-0.002279,-0.003011,-0.003425,-0.003151,-0.003425,-0.002271,-0.003285,-0.003011,-0.002279,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.002279,-0.003285,-0.002190,-0.003285,-0.002279,-0.003285,-0.003011,-0.003011,-0.003285,-0.003151,-0.001509,-0.003358,-0.001916,-0.003285,-0.003425,-0.002279,-0.004794,-0.001509,-0.001916,-0.003425,-0.002279,-0.003285,-0.003425,-0.002279,-0.001509,-0.003425,-0.003151,-0.002190,-0.003285,-0.003285,-0.003011,-0.003285,-0.003425,-0.002279,-0.002190,-0.001509,-0.003011,-0.003285,-0.002279,-0.003285,-0.001916,-0.002279,-0.001916,-0.003425,-0.002190,-0.003285,-0.005341,-0.003425,-0.003285,-0.001916,-0.001509,-0.003151,-0.002279,-0.003285,-0.003003,-0.003285,-0.003425,-0.001916,-0.003011,-0.002279,-0.001783,-0.003285,-0.003011,-0.003425,-0.003285,-0.003151,-0.001509,-0.003285,-0.001509,-0.001509,-0.003003,-0.002279,-0.005341,-0.003003,-0.003285,-0.003151,-0.003285,-0.002190,-0.003425,-0.001509,-0.003285,-0.001509,-0.002279,-0.001509,-0.003425,-0.001916,-0.003285,-0.002190,-0.003151,-0.001916,-0.001509,-0.003285,-0.003425,-0.002279,-0.001783,-0.005208,-0.001509,-0.001783,-0.002279,-0.003285,-0.003425,-0.003425,-0.002279,-0.003011,-0.001916,-0.002190,-0.003285,-0.003285,-0.003285,-0.001783,-0.001502,-0.001910,-0.003699,-0.003011,-0.002279,-0.001916,-0.003425,-0.003285,-0.002279,-0.003151,-0.003285,-0.002190,-0.003425,-0.001509,-0.003285,-0.003003,-0.003285,-0.003011,-0.003151,-0.003425,-0.001509,-0.003285,-0.002190,-0.002279,-0.002190,-0.001509,-0.003011,-0.003285,-0.003011,-0.002279,-0.003285,-0.001916,-0.002279,-0.003011,-0.003285,-0.001509,-0.003285,-0.003151,-0.001916,-0.001509,-0.003003,-0.003285,-0.002279,-0.003839,-0.003935,-0.003558,-0.002604,-0.003551,-0.002279,-0.001509,-0.003425,-0.003425,-0.001509,-0.003425,-0.001509,-0.001916,-0.003285,-0.002190,-0.003011,-0.001775]},{w:"may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. Patients with signiﬁ  cant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with EXINEF after ",p:[0.080772,0.881028,0.940128,0.881028,0.940128,0.874294,0.080772,0.874294,-0.005341,-0.003285,-0.003003,-0.002789,-0.001509,-0.003425,-0.003151,-0.002190,-0.003285,-0.003285,-0.003011,-0.003285,-0.002789,-0.004794,-0.001509,-0.001916,-0.003425,-0.002789,-0.003425,-0.003285,-0.003011,-0.003285,-0.002789,-0.003285,-0.003425,-0.003425,-0.002789,-0.003425,-0.003425,-0.002190,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.002789,-0.003285,-0.001916,-0.002789,-0.003285,-0.003003,-0.003425,-0.003285,-0.003011,-0.003425,-0.002190,-0.003285,-0.001502,-0.002789,-0.001916,-0.003425,-0.003285,-0.002789,-0.003011,-0.003425,-0.003285,-0.002190,-0.001916,-0.003285,-0.003011,-0.001916,-0.002789,-0.003425,-0.003425,-0.002190,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.002789,-0.003425,-0.003285,-0.003011,-0.003011,-0.001509,-0.003425,-0.001509,-0.003285,-0.002789,-0.003285,-0.003425,-0.003425,-0.002789,-0.001916,-0.003425,-0.003285,-0.002789,-0.001509,-0.003358,-0.004794,-0.003285,-0.003011,-0.001916,-0.002789,-0.003285,-0.001916,-0.001916,-0.003285,-0.003151,-0.001916,-0.001509,-0.003003,-0.003285,-0.002789,-0.003425,-0.003285,-0.001509,-0.001509,-0.003003,-0.002789,-0.003425,-0.003285,-0.003011,-0.003285,-0.002789,-0.003011,-0.003425,-0.003285,-0.003425,-0.001509,-0.003425,-0.002789,-0.003425,-0.003285,-0.002789,-0.003418,-0.003011,-0.003285,-0.003425,-0.001502,-0.002789,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.002789,-0.004794,-0.001509,-0.001916,-0.003425,-0.002789,-0.003011,-0.001509,-0.003425,-0.003425,-0.001509,-0.003425,0.001716,-0.001709,-0.003151,-0.003285,-0.003425,-0.001916,-0.002789,-0.002190,-0.001509,-0.003011,-0.003285,-0.002789,-0.001916,-0.003285,-0.003151,-0.001916,-0.003285,-0.002190,-0.003011,-0.002789,-0.001916,-0.003285,-0.002190,-0.002789,-0.003151,-0.003285,-0.002190,-0.003425,-0.001509,-0.003285,-0.003003,-0.003285,-0.003011,-0.003151,-0.003425,-0.001509,-0.003285,-0.002190,-0.002789,-0.003285,-0.003003,-0.003285,-0.003425,-0.001916,-0.003011,-0.002789,-0.001783,-0.003285,-0.001775,-0.003425,-0.001502,-0.002789,-0.003425,-0.003003,-0.003425,-0.003285,-0.002190,-0.001916,-0.003285,-0.003425,-0.003011,-0.001509,-0.003285,-0.003425,-0.001502,-0.002789,-0.003425,-0.003003,-0.003425,-0.003285,-0.002190,-0.001509,-0.001509,-0.003425,-0.001509,-0.003425,-0.003285,-0.003285,-0.005341,-0.001509,-0.003285,-0.001502,-0.002789,-0.003425,-0.001509,-0.003285,-0.003425,-0.003285,-0.001916,-0.003285,-0.003011,-0.002789,-0.005341,-0.003285,-0.001509,-0.001509,-0.001509,-0.001916,-0.003425,-0.003011,-0.001502,-0.002789,-0.003011,-0.005341,-0.003285,-0.003285,-0.001509,-0.003425,-0.003425,-0.001783,-0.002789,-0.003011,-0.003425,-0.003285,-0.003425,-0.001509,-0.003425,-0.002789,-0.003285,-0.003425,-0.001509,-0.003003,-0.002789,-0.003425,-0.003285,-0.002789,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.003285,-0.003425,-0.002789,-0.004794,-0.001509,-0.001916,-0.003425,-0.002789,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.002789,-0.003285,-0.001916,-0.001916,-0.003285,-0.002190,-0.001775]},{w:"careful consideration. ",p:[0.080772,0.887944,0.142015,0.887944,0.142015,0.881210,0.080772,0.881210,-0.003151,-0.003285,-0.002190,-0.003285,-0.001916,-0.003425,-0.001509,-0.002434,-0.003151,-0.003285,-0.003425,-0.003011,-0.001509,-0.003425,-0.003285,-0.002190,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001502,-0.001775]},{w:"EXINEF is not a substitute for aspirin for cardiovascular prophylaxis because of its lack of effect on platelets",p:[0.142674,0.888015,0.471668,0.888015,0.471668,0.881040,0.142674,0.881040,-0.003558,-0.003972,-0.001909,-0.004246,-0.003558,-0.003425,-0.002434,-0.001775,-0.003285,-0.002434,-0.003699,-0.003551,-0.002190,-0.002434,-0.003558,-0.002434,-0.003285,-0.003699,-0.003699,-0.003285,-0.002190,-0.001775,-0.002190,-0.003699,-0.002190,-0.003425,-0.002434,-0.002190,-0.003551,-0.002463,-0.002434,-0.003558,-0.003285,-0.003699,-0.001775,-0.002463,-0.001775,-0.003699,-0.002434,-0.002190,-0.003551,-0.002463,-0.002434,-0.003425,-0.003558,-0.002463,-0.003699,-0.001775,-0.003625,-0.003166,-0.003558,-0.003285,-0.003425,-0.003699,-0.001775,-0.003558,-0.002463,-0.002434,-0.003699,-0.002463,-0.003551,-0.003699,-0.003699,-0.003285,-0.001775,-0.003558,-0.003418,-0.001775,-0.003285,-0.002434,-0.003699,-0.003425,-0.003425,-0.003558,-0.003699,-0.003285,-0.003425,-0.002434,-0.003551,-0.002190,-0.002434,-0.001775,-0.002190,-0.003285,-0.002434,-0.001775,-0.003558,-0.003425,-0.003699,-0.002434,-0.003551,-0.002190,-0.002434,-0.003425,-0.002190,-0.002190,-0.003425,-0.003425,-0.002190,-0.002434,-0.003551,-0.003699,-0.002434,-0.003699,-0.001775,-0.003558,-0.002190,-0.003425,-0.001775,-0.003425,-0.002190,-0.003285]},{w:". When using EXINEF in the elderly and in patients with renal, hepatic or cardiac dysfunction, medically appropriate supervision should be intensiﬁ  ed. If these patients ",p:[0.471690,0.887944,0.940112,0.887944,0.940112,0.881210,0.471690,0.881210,-0.001502,-0.002160,-0.005341,-0.003425,-0.003285,-0.003425,-0.002434,-0.003425,-0.003011,-0.001509,-0.003425,-0.003425,-0.002434,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.002434,-0.001509,-0.003425,-0.002434,-0.001916,-0.003425,-0.003285,-0.002434,-0.003285,-0.001509,-0.003425,-0.003285,-0.002190,-0.001509,-0.003003,-0.002434,-0.003285,-0.003425,-0.003425,-0.002434,-0.001509,-0.003425,-0.002434,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.002434,-0.004794,-0.001509,-0.001916,-0.003425,-0.002434,-0.002190,-0.003285,-0.003425,-0.003285,-0.001509,-0.001502,-0.002434,-0.003425,-0.003285,-0.003425,-0.003358,-0.001916,-0.001509,-0.003151,-0.002434,-0.003285,-0.002190,-0.002434,-0.003151,-0.003285,-0.002190,-0.003425,-0.001509,-0.003285,-0.003151,-0.002434,-0.003499,-0.003003,-0.003011,-0.001916,-0.003425,-0.003425,-0.003151,-0.001916,-0.001509,-0.003285,-0.003425,-0.001502,-0.002434,-0.005341,-0.003285,-0.003425,-0.001509,-0.003151,-0.003285,-0.001509,-0.001509,-0.003003,-0.002434,-0.003358,-0.003425,-0.003425,-0.002190,-0.003285,-0.003425,-0.002190,-0.001509,-0.003358,-0.001916,-0.003285,-0.002434,-0.003011,-0.003425,-0.003425,-0.003285,-0.002323,-0.003003,-0.001509,-0.003011,-0.001509,-0.003306,-0.003425,-0.002434,-0.003011,-0.003425,-0.003285,-0.003425,-0.001509,-0.003425,-0.002434,-0.003425,-0.003285,-0.002434,-0.001509,-0.003425,-0.001916,-0.003285,-0.003425,-0.003011,-0.001509,-0.003425,0.001716,-0.001709,-0.003285,-0.003425,-0.001502,-0.002434,-0.001509,-0.001916,-0.002434,-0.001916,-0.003425,-0.003285,-0.003011,-0.003285,-0.002434,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.001775]},{w:"deteriorate during treatment, appropriate measures should be taken, including discontinuation of EXINEF. Upper GI complications, some of them resulting in fatal outcome, have occurred in patients treated with EXINEF. There is an increase in the risk of gastrointestinal adverse effects when EXINEF is taken ",p:[0.080779,0.894860,0.940135,0.894860,0.940135,0.888127,0.080779,0.888127,-0.003425,-0.003285,-0.001916,-0.003285,-0.002190,-0.001509,-0.003285,-0.002190,-0.003358,-0.001916,-0.003285,-0.002352,-0.003425,-0.003425,-0.002190,-0.001509,-0.003425,-0.003425,-0.002352,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.005341,-0.003285,-0.003425,-0.001916,-0.001502,-0.002352,-0.003358,-0.003425,-0.003425,-0.002190,-0.003285,-0.003425,-0.002190,-0.001509,-0.003358,-0.001916,-0.003285,-0.002352,-0.005341,-0.003285,-0.003285,-0.003011,-0.003425,-0.002190,-0.003285,-0.003011,-0.002352,-0.003011,-0.003425,-0.003285,-0.003425,-0.001509,-0.003425,-0.002352,-0.003425,-0.003285,-0.002352,-0.001916,-0.003285,-0.003285,-0.003285,-0.003425,-0.001502,-0.002352,-0.001509,-0.003425,-0.003003,-0.001509,-0.003425,-0.003425,-0.001509,-0.003425,-0.003425,-0.002352,-0.003425,-0.001509,-0.003011,-0.003151,-0.003285,-0.003425,-0.001916,-0.001509,-0.003425,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.002352,-0.003285,-0.001916,-0.002352,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.002463,-0.001502,-0.002352,-0.003839,-0.003425,-0.003425,-0.003285,-0.002190,-0.002352,-0.003972,-0.001509,-0.002352,-0.003151,-0.003285,-0.005341,-0.003425,-0.001509,-0.001509,-0.003151,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.003011,-0.001502,-0.002352,-0.003011,-0.003285,-0.005341,-0.003285,-0.002352,-0.003285,-0.001916,-0.002352,-0.001916,-0.003425,-0.003285,-0.005341,-0.002352,-0.002190,-0.003285,-0.003011,-0.003425,-0.001509,-0.001916,-0.001509,-0.003425,-0.003425,-0.002352,-0.001509,-0.003425,-0.002352,-0.001916,-0.003358,-0.001916,-0.003285,-0.001509,-0.002352,-0.003285,-0.003425,-0.001916,-0.003151,-0.003285,-0.005341,-0.003285,-0.001502,-0.002352,-0.003425,-0.003358,-0.003003,-0.003285,-0.002352,-0.003285,-0.003151,-0.003151,-0.003425,-0.002190,-0.002190,-0.003285,-0.003425,-0.002352,-0.001509,-0.003425,-0.002352,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.002352,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.003285,-0.003425,-0.002352,-0.004794,-0.001509,-0.001916,-0.003425,-0.002352,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.002463,-0.001502,-0.002079,-0.003425,-0.003425,-0.003285,-0.002190,-0.003285,-0.002352,-0.001509,-0.003011,-0.002352,-0.003285,-0.003425,-0.002352,-0.001509,-0.003425,-0.003151,-0.002190,-0.003285,-0.003285,-0.003011,-0.003285,-0.002352,-0.001509,-0.003425,-0.002352,-0.001916,-0.003425,-0.003285,-0.002352,-0.002190,-0.001509,-0.003011,-0.003285,-0.002352,-0.003285,-0.001916,-0.002352,-0.003425,-0.003285,-0.003011,-0.001916,-0.002190,-0.003285,-0.001509,-0.003425,-0.001916,-0.003285,-0.003011,-0.001916,-0.001509,-0.003425,-0.003285,-0.001509,-0.002352,-0.003285,-0.003425,-0.003003,-0.003285,-0.002190,-0.003011,-0.003285,-0.002352,-0.003285,-0.001916,-0.001916,-0.003285,-0.003151,-0.001916,-0.003011,-0.002352,-0.004794,-0.003425,-0.003285,-0.003425,-0.002352,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.002352,-0.001509,-0.003011,-0.002352,-0.001916,-0.003285,-0.003285,-0.003285,-0.003425,-0.001775]},{w:"concomitantly with aspirin (even at low doses). Elevations of alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) (approximately 3 or more times the upper limit of normal) have been reported in approximately 1 % of patients in clinical trials treated for up to one year with EXINEF 60 and",p:[0.080779,0.901777,0.938278,0.901777,0.938278,0.895043,0.080779,0.895043,-0.003151,-0.003285,-0.003425,-0.003151,-0.003285,-0.005341,-0.001509,-0.001916,-0.003285,-0.003425,-0.001916,-0.001509,-0.003003,-0.002242,-0.004794,-0.001509,-0.001916,-0.003425,-0.002242,-0.003285,-0.003011,-0.003425,-0.001509,-0.002190,-0.001509,-0.003425,-0.002242,-0.001783,-0.003285,-0.003003,-0.003285,-0.003425,-0.002242,-0.003358,-0.001916,-0.002242,-0.001509,-0.003358,-0.004794,-0.002242,-0.003425,-0.003285,-0.003011,-0.003285,-0.003011,-0.001783,-0.001502,-0.002242,-0.003425,-0.001509,-0.003285,-0.003003,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.003011,-0.002242,-0.003285,-0.001916,-0.002242,-0.003285,-0.001509,-0.003285,-0.003425,-0.001509,-0.003425,-0.003285,-0.002242,-0.003285,-0.005341,-0.001509,-0.003425,-0.003285,-0.001916,-0.002190,-0.003285,-0.003425,-0.003011,-0.001916,-0.003285,-0.002190,-0.003285,-0.003011,-0.003285,-0.002242,-0.001783,-0.003699,-0.002589,-0.003425,-0.001783,-0.002242,-0.003285,-0.003425,-0.003425,-0.002057,-0.003285,-0.002190,-0.002242,-0.003285,-0.003011,-0.003425,-0.003285,-0.002190,-0.001916,-0.003358,-0.001916,-0.003285,-0.002242,-0.003285,-0.005341,-0.001509,-0.003425,-0.003285,-0.001916,-0.002190,-0.003285,-0.003425,-0.003011,-0.001916,-0.003285,-0.002190,-0.003285,-0.003011,-0.003285,-0.002242,-0.001783,-0.003699,-0.003699,-0.003425,-0.001783,-0.002242,-0.001783,-0.003358,-0.003425,-0.003425,-0.002190,-0.003285,-0.003003,-0.001509,-0.005341,-0.003358,-0.001916,-0.003285,-0.001509,-0.003003,-0.002242,-0.003551,-0.002242,-0.003285,-0.002190,-0.002242,-0.005341,-0.003285,-0.002190,-0.003285,-0.002242,-0.001916,-0.001509,-0.005341,-0.003285,-0.003011,-0.002242,-0.001916,-0.003425,-0.003285,-0.002242,-0.003425,-0.003425,-0.003425,-0.003285,-0.002190,-0.002242,-0.001509,-0.001509,-0.005341,-0.001509,-0.001916,-0.002242,-0.003285,-0.001916,-0.002242,-0.003425,-0.003285,-0.002190,-0.005341,-0.003285,-0.001509,-0.001783,-0.002242,-0.003425,-0.003358,-0.003003,-0.003285,-0.002242,-0.003425,-0.003285,-0.003285,-0.003425,-0.002242,-0.002190,-0.003285,-0.003425,-0.003285,-0.002190,-0.001916,-0.003285,-0.003425,-0.002242,-0.001509,-0.003425,-0.002242,-0.003358,-0.003425,-0.003425,-0.002190,-0.003285,-0.003003,-0.001509,-0.005341,-0.003358,-0.001916,-0.003285,-0.001509,-0.003003,-0.002242,-0.003551,-0.002242,-0.005615,-0.002242,-0.003285,-0.001916,-0.002242,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.002242,-0.001509,-0.003425,-0.002242,-0.003003,-0.001509,-0.001509,-0.003425,-0.001509,-0.003151,-0.003285,-0.001509,-0.002242,-0.001916,-0.002190,-0.001509,-0.003285,-0.001509,-0.003011,-0.002242,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.003285,-0.003425,-0.002242,-0.001916,-0.003285,-0.002190,-0.002242,-0.003425,-0.003425,-0.002242,-0.001916,-0.003285,-0.002242,-0.003285,-0.003425,-0.003285,-0.002242,-0.003003,-0.003285,-0.003285,-0.002190,-0.002242,-0.004794,-0.001509,-0.001916,-0.003425,-0.002242,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.002242,-0.003551,-0.003551,-0.002242,-0.003285,-0.003425,-0.003425]},{w:"90 mg daily. EXINEF may mask fever and other signs of inﬂ  ammation or infection. EXINEF Tablets contain lactose. Patients with hereditary problems of galactose intolerance, the Lapp lactase deﬁ  ciency or glucose-galactose malabsorption should not take EXINEF. The use of EXINEF is not recommended in fertile women ",p:[0.080779,0.908693,0.940129,0.908693,0.940129,0.901959,0.080779,0.901959,-0.003551,-0.003551,-0.001561,-0.005341,-0.003425,-0.001561,-0.003425,-0.003285,-0.001509,-0.001509,-0.002596,-0.001502,-0.001561,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.001561,-0.005341,-0.003285,-0.003003,-0.001561,-0.005341,-0.003285,-0.003011,-0.003285,-0.001561,-0.001916,-0.003285,-0.003003,-0.003285,-0.002190,-0.001561,-0.003285,-0.003425,-0.003425,-0.001561,-0.003285,-0.001916,-0.003425,-0.003285,-0.002190,-0.001561,-0.003011,-0.001509,-0.003425,-0.003425,-0.003011,-0.001561,-0.003285,-0.001916,-0.001561,-0.001509,-0.003425,-0.003425,0.001716,-0.001709,-0.003285,-0.005341,-0.005341,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001561,-0.003285,-0.002190,-0.001561,-0.001509,-0.003425,-0.001916,-0.003285,-0.003151,-0.001916,-0.001509,-0.003285,-0.003425,-0.001502,-0.001561,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.001287,-0.002878,-0.003285,-0.003425,-0.001509,-0.003285,-0.001916,-0.003011,-0.001561,-0.003151,-0.003285,-0.003425,-0.001916,-0.003285,-0.001509,-0.003425,-0.001561,-0.001509,-0.003285,-0.003151,-0.001916,-0.003285,-0.003011,-0.003285,-0.001502,-0.001561,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.001561,-0.004794,-0.001509,-0.001916,-0.003425,-0.001555,-0.003425,-0.003285,-0.002190,-0.003285,-0.003425,-0.001509,-0.001916,-0.003285,-0.002322,-0.003003,-0.001561,-0.003425,-0.002190,-0.003285,-0.003425,-0.001509,-0.003285,-0.005341,-0.003011,-0.001561,-0.003285,-0.001916,-0.001561,-0.003425,-0.003285,-0.001509,-0.003285,-0.003151,-0.001916,-0.003285,-0.003011,-0.003285,-0.001561,-0.001509,-0.003425,-0.001916,-0.003285,-0.001509,-0.003285,-0.002190,-0.003285,-0.003425,-0.003151,-0.003285,-0.001502,-0.001561,-0.001916,-0.003425,-0.003285,-0.001561,-0.003285,-0.003358,-0.003425,-0.003425,-0.001561,-0.001509,-0.003285,-0.003151,-0.001916,-0.003285,-0.003011,-0.003285,-0.001561,-0.003425,-0.003285,-0.003425,0.001716,-0.001716,-0.003151,-0.001509,-0.003285,-0.003425,-0.003003,-0.003003,-0.001561,-0.003285,-0.002190,-0.001561,-0.003425,-0.001509,-0.003425,-0.003151,-0.003285,-0.003011,-0.003285,-0.002604,-0.003425,-0.003285,-0.001509,-0.003285,-0.003151,-0.001916,-0.003285,-0.003011,-0.003285,-0.001561,-0.005341,-0.003285,-0.001509,-0.003285,-0.003425,-0.003011,-0.003285,-0.002190,-0.003425,-0.001916,-0.001509,-0.003285,-0.003425,-0.001561,-0.003011,-0.003425,-0.003285,-0.003425,-0.001509,-0.003425,-0.001561,-0.003425,-0.003285,-0.001916,-0.001561,-0.001916,-0.003285,-0.003285,-0.003285,-0.001561,-0.003425,-0.003545,-0.001509,-0.004113,-0.003425,-0.002463,-0.001502,-0.001287,-0.003425,-0.003425,-0.003285,-0.001561,-0.003425,-0.003011,-0.003285,-0.001561,-0.003285,-0.001916,-0.001561,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.001561,-0.001509,-0.003011,-0.001561,-0.003425,-0.003285,-0.001916,-0.001561,-0.002190,-0.003285,-0.003151,-0.003285,-0.005341,-0.005341,-0.003285,-0.003425,-0.003425,-0.003285,-0.003425,-0.001561,-0.001509,-0.003425,-0.001561,-0.001916,-0.003285,-0.002190,-0.001916,-0.001509,-0.001509,-0.003285,-0.001561,-0.004794,-0.003285,-0.005341,-0.003285,-0.003425,-0.001775]},{w:"attempting to conceive. ",p:[0.080772,0.915610,0.146232,0.915610,0.146232,0.908876,0.080772,0.908876,-0.003358,-0.001916,-0.001916,-0.003285,-0.005341,-0.003425,-0.001916,-0.001509,-0.003425,-0.003425,-0.001687,-0.001916,-0.003285,-0.001687,-0.003151,-0.003285,-0.003425,-0.003151,-0.003285,-0.001509,-0.003003,-0.003285,-0.001502,-0.001775]},{w:"SIDE EFFECTS: ",p:[0.146136,0.915680,0.190254,0.915680,0.190254,0.908705,0.146136,0.908705,-0.003839,-0.001909,-0.004246,-0.003558,-0.001687,-0.003558,-0.003425,-0.003425,-0.003558,-0.003972,-0.003551,-0.003839,-0.001775,-0.001775]},{w:"In clinical studies, the undesirable effects proﬁ  le was similar in patients with OA or RA treated with EXINEF for one year or longer. Very common (≥ 1/10) and Common (≥ 1/100, < 1/10) reported effects: alveolar osteitis, oedema/ﬂ  uid retention, dizziness, headache, palpitations, ",p:[0.190165,0.915610,0.940125,0.915610,0.940125,0.908876,0.190165,0.908876,-0.001509,-0.003425,-0.001687,-0.003003,-0.001509,-0.001509,-0.003425,-0.001509,-0.003151,-0.003285,-0.001509,-0.001687,-0.003011,-0.001916,-0.003425,-0.003425,-0.001509,-0.003285,-0.003011,-0.001502,-0.001687,-0.001916,-0.003425,-0.003285,-0.001687,-0.003425,-0.003425,-0.003425,-0.003285,-0.003011,-0.001509,-0.002190,-0.003285,-0.003425,-0.001509,-0.003285,-0.001687,-0.003285,-0.001916,-0.001916,-0.003285,-0.003151,-0.001916,-0.003011,-0.001687,-0.003425,-0.002190,-0.003285,-0.003425,0.001716,-0.001687,-0.001509,-0.003285,-0.001687,-0.004794,-0.003285,-0.003011,-0.001687,-0.003011,-0.001509,-0.005341,-0.001509,-0.001509,-0.003285,-0.002190,-0.001687,-0.001509,-0.003425,-0.001687,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001916,-0.003011,-0.001687,-0.004794,-0.001509,-0.001916,-0.003425,-0.001687,-0.004113,-0.003699,-0.001687,-0.003285,-0.002190,-0.001687,-0.003839,-0.003699,-0.001687,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.003285,-0.003425,-0.001687,-0.004794,-0.001509,-0.001916,-0.003425,-0.001687,-0.003425,-0.003558,-0.001509,-0.004113,-0.003425,-0.003285,-0.001687,-0.001916,-0.003285,-0.002190,-0.001687,-0.003285,-0.003425,-0.003285,-0.001687,-0.003003,-0.003285,-0.003285,-0.002190,-0.001687,-0.003285,-0.002190,-0.001648,-0.001509,-0.003285,-0.003425,-0.003425,-0.003285,-0.001642,-0.001502,-0.001413,-0.003285,-0.003285,-0.002323,-0.003003,-0.001687,-0.003151,-0.003285,-0.005341,-0.005341,-0.003285,-0.003425,-0.001687,-0.001783,-0.003676,-0.001687,-0.003551,-0.002057,-0.003551,-0.003551,-0.001783,-0.001687,-0.003285,-0.003425,-0.003425,-0.001687,-0.003839,-0.003285,-0.005341,-0.005341,-0.003285,-0.003425,-0.001687,-0.001783,-0.003676,-0.001687,-0.003551,-0.002057,-0.003551,-0.003551,-0.003551,-0.001502,-0.001687,-0.004438,-0.001687,-0.003551,-0.002057,-0.003551,-0.003551,-0.001783,-0.001687,-0.002190,-0.003285,-0.003425,-0.003285,-0.002190,-0.001916,-0.003285,-0.003425,-0.001687,-0.003285,-0.001916,-0.001916,-0.003285,-0.003151,-0.001916,-0.003011,-0.001502,-0.001687,-0.003285,-0.001509,-0.003003,-0.003285,-0.003285,-0.001509,-0.003285,-0.002190,-0.001687,-0.003285,-0.003011,-0.001916,-0.003285,-0.001509,-0.001916,-0.001509,-0.003011,-0.001502,-0.001687,-0.003285,-0.003285,-0.003425,-0.003285,-0.005341,-0.003285,-0.002057,-0.003425,0.001716,-0.001687,-0.003425,-0.001509,-0.003425,-0.001687,-0.002190,-0.003285,-0.001916,-0.003285,-0.003425,-0.001916,-0.001509,-0.003285,-0.003425,-0.001502,-0.001687,-0.003425,-0.001509,-0.002878,-0.002878,-0.001509,-0.003425,-0.003285,-0.002995,-0.003011,-0.001502,-0.001687,-0.003425,-0.003285,-0.003285,-0.003425,-0.003285,-0.003151,-0.003425,-0.003285,-0.001502,-0.001687,-0.003425,-0.003285,-0.001509,-0.003425,-0.001509,-0.001916,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.003011,-0.001502,-0.001775]},{w:"hypertension, gastrointestinal disorders (e.g. abdominal pain, ﬂ  atulence, heartburn), diarrhoea, dyspepsia, epigastric discomfort, nausea, ecchymosis, asthenia/fatigue, ﬂ  u-like disease, increased ALT, AST.",p:[0.080772,0.922526,0.633739,0.922526,0.633739,0.915792,0.080772,0.915792,-0.003425,-0.003003,-0.003425,-0.003285,-0.002190,-0.001916,-0.003285,-0.003425,-0.003011,-0.001509,-0.003285,-0.003425,-0.001502,-0.001775,-0.003425,-0.003285,-0.003011,-0.001916,-0.002190,-0.003285,-0.001509,-0.003425,-0.001916,-0.003285,-0.003011,-0.001916,-0.001509,-0.003425,-0.003285,-0.001509,-0.001775,-0.003425,-0.001509,-0.003011,-0.003285,-0.002190,-0.003425,-0.003285,-0.002190,-0.003011,-0.001775,-0.001783,-0.003285,-0.001775,-0.003425,-0.001494,-0.001775,-0.003285,-0.003425,-0.003425,-0.003285,-0.005341,-0.001509,-0.003425,-0.003285,-0.001509,-0.001775,-0.003425,-0.003285,-0.001509,-0.003425,-0.001494,-0.001775,-0.003425,0.001716,-0.001709,-0.003358,-0.001916,-0.003425,-0.001509,-0.003285,-0.003425,-0.003151,-0.003285,-0.001502,-0.001775,-0.003425,-0.003285,-0.003285,-0.002190,-0.001916,-0.003425,-0.003425,-0.002190,-0.003425,-0.001783,-0.001502,-0.001775,-0.003425,-0.001509,-0.003285,-0.002190,-0.002190,-0.003425,-0.003285,-0.003285,-0.003285,-0.001502,-0.001775,-0.003499,-0.003003,-0.003011,-0.003425,-0.003285,-0.003425,-0.003011,-0.001509,-0.003285,-0.001502,-0.001775,-0.003285,-0.003425,-0.001509,-0.003425,-0.003285,-0.003011,-0.001916,-0.002190,-0.001509,-0.003151,-0.001775,-0.003425,-0.001509,-0.003011,-0.003151,-0.003285,-0.005341,-0.001931,-0.003285,-0.002190,-0.001916,-0.001502,-0.001775,-0.003425,-0.003285,-0.003425,-0.003011,-0.003285,-0.003285,-0.001502,-0.001775,-0.003285,-0.003151,-0.003151,-0.003425,-0.003003,-0.005341,-0.003285,-0.003011,-0.001509,-0.003011,-0.001502,-0.001775,-0.003285,-0.003011,-0.001916,-0.003425,-0.003285,-0.003425,-0.001509,-0.003285,-0.002057,-0.001916,-0.003358,-0.001916,-0.001509,-0.003425,-0.003425,-0.003285,-0.001502,-0.001775,-0.003425,0.001716,-0.001709,-0.003425,-0.002604,-0.001509,-0.001509,-0.003285,-0.003285,-0.001775,-0.003425,-0.001509,-0.003011,-0.003285,-0.003285,-0.003011,-0.003285,-0.001502,-0.001775,-0.001509,-0.003425,-0.003151,-0.002190,-0.003285,-0.003285,-0.003011,-0.003285,-0.003425,-0.001502,-0.003699,-0.002589,-0.002744,-0.001502,-0.001502,-0.003699,-0.003699,-0.002744,-0.001775]},{w:"REFERENCES: ",p:[0.080517,0.789632,0.122774,0.789632,0.122774,0.782557,0.080517,0.782557,-0.004198,-0.003657,-0.003518,-0.003657,-0.004198,-0.003657,-0.004330,-0.003927,-0.003657,-0.003927,-0.001631,-0.001901]},{w:"1",p:[0.122701,0.789596,0.126211,0.789596,0.126211,0.782621,0.122701,0.782621,-0.003510]},{w:". Approved ARCOXIA package insert, October 2013.   . Approved EXINEF package insert, November 2014.   . Lin H-Y, Cheng T-T, Wang J-H, ",p:[0.126211,0.789526,0.500021,0.789526,0.500021,0.782792,0.126211,0.782792,-0.001485,-0.001419,-0.003730,-0.003386,-0.003386,-0.002165,-0.003247,-0.002969,-0.003247,-0.003386,-0.001419,-0.003657,-0.003796,-0.003796,-0.003891,-0.003518,-0.001492,-0.003657,-0.001689,-0.003386,-0.003247,-0.003116,-0.003247,-0.003320,-0.003386,-0.003247,-0.001689,-0.001492,-0.003386,-0.002977,-0.003247,-0.002165,-0.001894,-0.001485,-0.001689,-0.004066,-0.003116,-0.001894,-0.003247,-0.003386,-0.003247,-0.002165,-0.001689,-0.003510,-0.003510,-0.003510,-0.003510,-0.001485,-0.001689,-0.001755,-0.003423,-0.001485,-0.001419,-0.003730,-0.003386,-0.003386,-0.002165,-0.003247,-0.002969,-0.003247,-0.003386,-0.001689,-0.003386,-0.003518,-0.001492,-0.004066,-0.003386,-0.003247,-0.001689,-0.003386,-0.003247,-0.003116,-0.003247,-0.003320,-0.003386,-0.003247,-0.001689,-0.001492,-0.003386,-0.002977,-0.003247,-0.002165,-0.001894,-0.001485,-0.001689,-0.004066,-0.003247,-0.002969,-0.003247,-0.005280,-0.003386,-0.003247,-0.002165,-0.001689,-0.003510,-0.003510,-0.003510,-0.003510,-0.001485,-0.001689,-0.001755,-0.003423,-0.001485,-0.001689,-0.003247,-0.001492,-0.003386,-0.001689,-0.003927,-0.002574,-0.002567,-0.001485,-0.001689,-0.003796,-0.003386,-0.003247,-0.003386,-0.003386,-0.001419,-0.002984,-0.002574,-0.002713,-0.001485,-0.001419,-0.005149,-0.003247,-0.003386,-0.003386,-0.001689,-0.003116,-0.002574,-0.003927,-0.001485,-0.001755]},{w:"2",p:[0.266211,0.789596,0.269722,0.789596,0.269722,0.782621,0.266211,0.782621,-0.003510]},{w:"3",p:[0.411770,0.789596,0.415280,0.789596,0.415280,0.782621,0.411770,0.782621,-0.003510]},{w:"et al. ",p:[0.499933,0.789879,0.514743,0.789879,0.514743,0.782792,0.499933,0.782792,-0.003247,-0.001894,-0.001689,-0.003247,-0.001492,-0.001485,-0.001755]},{w:"Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial",p:[0.514677,0.789526,0.765387,0.789526,0.765387,0.782792,0.514677,0.782792,-0.003386,-0.001894,-0.003247,-0.002165,-0.001492,-0.003116,-0.003247,-0.002969,-0.001492,-0.003386,-0.001689,-0.001492,-0.005280,-0.003386,-0.002165,-0.003247,-0.002969,-0.003247,-0.002977,-0.001689,-0.003386,-0.003247,-0.001492,-0.003386,-0.001485,-0.001689,-0.001894,-0.003386,-0.003386,-0.003116,-0.001894,-0.001492,-0.003247,-0.003386,-0.001689,-0.003247,-0.003386,-0.003386,-0.001689,-0.003386,-0.003386,-0.003247,-0.001492,-0.001492,-0.001894,-0.002969,-0.001689,-0.003247,-0.001894,-0.001689,-0.001492,-0.001492,-0.001894,-0.003247,-0.001485,-0.001689,-0.002165,-0.003247,-0.002977,-0.003386,-0.001492,-0.001894,-0.002977,-0.001689,-0.003247,-0.001894,-0.001689,-0.003247,-0.001689,-0.002165,-0.003247,-0.003247,-0.001492,-0.002574,-0.004739,-0.003247,-0.002165,-0.001492,-0.003386,-0.001689,-0.003247,-0.001894,-0.001894,-0.003247,-0.003116,-0.001894,-0.001492,-0.002969,-0.003247,-0.003386,-0.003247,-0.002977,-0.002977,-0.001689,-0.001894,-0.002165,-0.001492,-0.003247,-0.001492]},{w:". Int J Rheum Dis. ",p:[0.765336,0.789879,0.814336,0.789879,0.814336,0.782792,0.765336,0.782792,-0.001485,-0.001689,-0.001492,-0.003386,-0.001894,-0.001689,-0.003116,-0.001689,-0.003796,-0.003386,-0.003247,-0.003386,-0.005280,-0.001689,-0.004066,-0.001492,-0.002977,-0.001485,-0.001755]},{w:"2010;13(2):144-150.   . Moore RA, Moore OA, ",p:[0.814270,0.789526,0.940119,0.789526,0.940119,0.782792,0.814270,0.782792,-0.003510,-0.003510,-0.003510,-0.003510,-0.001755,-0.003510,-0.003510,-0.001763,-0.003510,-0.001763,-0.001755,-0.003510,-0.003510,-0.003510,-0.002574,-0.003510,-0.003510,-0.003510,-0.001485,-0.001689,-0.001755,-0.003423,-0.001485,-0.001689,-0.005149,-0.003247,-0.003247,-0.002165,-0.003247,-0.001689,-0.003796,-0.003657,-0.001485,-0.001689,-0.005149,-0.003247,-0.003247,-0.002165,-0.003247,-0.001689,-0.004066,-0.003657,-0.001485,-0.001755]},{w:"4",p:[0.874357,0.789596,0.877868,0.789596,0.877868,0.782621,0.874357,0.782621,-0.003510]},{w:"Derry S, ",p:[0.080517,0.796442,0.103989,0.796442,0.103989,0.789708,0.080517,0.789708,-0.004113,-0.003285,-0.002190,-0.002323,-0.003003,-0.001583,-0.003699,-0.001502,-0.001775]},{w:"et al. ",p:[0.103797,0.796795,0.118651,0.796795,0.118651,0.789708,0.103797,0.789708,-0.003285,-0.001916,-0.001583,-0.003285,-0.001509,-0.001502,-0.001775]},{w:"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.",p:[0.118459,0.796442,0.587591,0.796442,0.587591,0.789708,0.118459,0.789708,-0.003839,-0.003285,-0.003011,-0.003425,-0.003285,-0.003425,-0.003425,-0.003285,-0.002190,-0.001583,-0.003285,-0.003425,-0.003285,-0.001509,-0.003003,-0.003011,-0.001509,-0.003011,-0.001583,-0.001916,-0.003285,-0.002190,-0.001583,-0.003425,-0.003285,-0.001509,-0.003425,-0.001583,-0.002190,-0.003285,-0.001509,-0.001509,-0.003285,-0.001916,-0.001583,-0.003285,-0.003425,-0.003425,-0.001583,-0.003425,-0.003425,-0.005341,-0.003425,-0.003285,-0.002190,-0.003011,-0.001583,-0.003425,-0.003285,-0.003285,-0.003425,-0.003285,-0.003425,-0.001583,-0.001916,-0.003285,-0.001583,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.001583,-0.001509,-0.003425,-0.001583,-0.003285,-0.001583,-0.005341,-0.003285,-0.001916,-0.003285,-0.002604,-0.003285,-0.003425,-0.003285,-0.001509,-0.003003,-0.003011,-0.001509,-0.003011,-0.001583,-0.003285,-0.001916,-0.001583,-0.003285,-0.001916,-0.003285,-0.002190,-0.001509,-0.003151,-0.003285,-0.003003,-0.001509,-0.003425,-0.001583,-0.003285,-0.003011,-0.001916,-0.003285,-0.003285,-0.003285,-0.002190,-0.001916,-0.003425,-0.002190,-0.001509,-0.001916,-0.001509,-0.003011,-0.001583,-0.001916,-0.002190,-0.001509,-0.003285,-0.001509,-0.003011,-0.001502,-0.001583,-0.003425,-0.002190,-0.001509,-0.003425,-0.003425,-0.001509,-0.003425,-0.003447,-0.001583,-0.003285,-0.001583,-0.003425,-0.003358,-0.003425,-0.001583,-0.003425,-0.003285,-0.001916,-0.004794,-0.003285,-0.003285,-0.003425,-0.001583,-0.003003,-0.001509,-0.001509,-0.003425,-0.001509,-0.003151,-0.003285,-0.001509,-0.001583,-0.001916,-0.002190,-0.001509,-0.003285,-0.001509,-0.003011,-0.001583,-0.003285,-0.003425,-0.003425,-0.001583,-0.003003,-0.001509,-0.001509,-0.003425,-0.001509,-0.003151,-0.003285,-0.001509,-0.001583,-0.003425,-0.002190,-0.003285,-0.003151,-0.001916,-0.001509,-0.003151,-0.003285,-0.001775]},{w:" Ann Rheum Dis. ",p:[0.587591,0.796795,0.633840,0.796795,0.633840,0.789708,0.587591,0.789708,-0.001309,-0.003699,-0.003425,-0.003425,-0.001583,-0.003839,-0.003425,-0.003285,-0.003425,-0.005341,-0.001583,-0.004113,-0.001509,-0.003011,-0.001502,-0.001775]},{w:"2010;69:374-379.   . Nor Azlin MI, Maryasalwati I, Norzilawati MN, ",p:[0.633647,0.796442,0.816439,0.796442,0.816439,0.789708,0.633647,0.789708,-0.003551,-0.003551,-0.003551,-0.003551,-0.001775,-0.003551,-0.003551,-0.001775,-0.003551,-0.003551,-0.003551,-0.002604,-0.003551,-0.003551,-0.003551,-0.001494,-0.001583,-0.001775,-0.003381,-0.001502,-0.001583,-0.004113,-0.003285,-0.002190,-0.001309,-0.003699,-0.002878,-0.001509,-0.001509,-0.003425,-0.001583,-0.005208,-0.001509,-0.001502,-0.001583,-0.005208,-0.003285,-0.002323,-0.003077,-0.003285,-0.003011,-0.003285,-0.001583,-0.004794,-0.003358,-0.001916,-0.001509,-0.001583,-0.001509,-0.001502,-0.001583,-0.004113,-0.003285,-0.002190,-0.002878,-0.001509,-0.001509,-0.003358,-0.004794,-0.003358,-0.001916,-0.001509,-0.001583,-0.005208,-0.004113,-0.001502,-0.001775]},{w:"5",p:[0.687094,0.796513,0.690645,0.796513,0.690645,0.789538,0.687094,0.789538,-0.003551]},{w:"et al. ",p:[0.816246,0.796795,0.831100,0.796795,0.831100,0.789708,0.816246,0.789708,-0.003285,-0.001916,-0.001583,-0.003285,-0.001509,-0.001502,-0.001775]},{w:"The efficacy of etoricoxib vs mefenamic ",p:[0.830908,0.796442,0.940109,0.796442,0.940109,0.789708,0.830908,0.789708,-0.003425,-0.003425,-0.003285,-0.001583,-0.003285,-0.001916,-0.001916,-0.001509,-0.003151,-0.003285,-0.003003,-0.003003,-0.001583,-0.003285,-0.001916,-0.001583,-0.003285,-0.001916,-0.003285,-0.002190,-0.001509,-0.003151,-0.003285,-0.003003,-0.001509,-0.003425,-0.001583,-0.003003,-0.003011,-0.001583,-0.005341,-0.003285,-0.001916,-0.003285,-0.003425,-0.003285,-0.005341,-0.001509,-0.003151,-0.001775]},{w:"acid in the treatment of primary dysmenorrhoea: A randomised comparative trial.",p:[0.080517,0.803359,0.299726,0.803359,0.299726,0.796625,0.080517,0.796625,-0.003285,-0.003151,-0.001509,-0.003425,-0.001583,-0.001509,-0.003425,-0.001583,-0.001916,-0.003425,-0.003285,-0.001583,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.005341,-0.003285,-0.003425,-0.001916,-0.001583,-0.003285,-0.001916,-0.001583,-0.003425,-0.002190,-0.001509,-0.005341,-0.003285,-0.002323,-0.003003,-0.001583,-0.003499,-0.003003,-0.003011,-0.005341,-0.003285,-0.003425,-0.003285,-0.002190,-0.002190,-0.003425,-0.003285,-0.003285,-0.003285,-0.001502,-0.001309,-0.003699,-0.001583,-0.002190,-0.003285,-0.003425,-0.003425,-0.003285,-0.005341,-0.001509,-0.003011,-0.003285,-0.003425,-0.001583,-0.003151,-0.003285,-0.005341,-0.003425,-0.003285,-0.002190,-0.003358,-0.001916,-0.001509,-0.003003,-0.003285,-0.001583,-0.001916,-0.002190,-0.001509,-0.003285,-0.001509,-0.001775]},{w:" Journal of Obstetrics and Gynaecology. ",p:[0.299704,0.803712,0.408321,0.803712,0.408321,0.796625,0.299704,0.796625,-0.001583,-0.003151,-0.003285,-0.003425,-0.002190,-0.003425,-0.003285,-0.001509,-0.001583,-0.003285,-0.001916,-0.001583,-0.004113,-0.003425,-0.003011,-0.001916,-0.003285,-0.001916,-0.002190,-0.001509,-0.003151,-0.003011,-0.001583,-0.003285,-0.003425,-0.003425,-0.001583,-0.003972,-0.003003,-0.003425,-0.003285,-0.003285,-0.003151,-0.003285,-0.001509,-0.003285,-0.003499,-0.002596,-0.001502,-0.001775]},{w:"2008;28(4):424-426.   . Viscusi ER, Frenkl TL, Hartrick CT, ",p:[0.408113,0.803359,0.566856,0.803359,0.566856,0.796625,0.408113,0.796625,-0.003551,-0.003551,-0.003551,-0.003551,-0.001775,-0.003551,-0.003551,-0.001783,-0.003551,-0.001783,-0.001775,-0.003551,-0.003551,-0.003551,-0.002604,-0.003551,-0.003551,-0.003551,-0.001494,-0.001583,-0.001775,-0.003358,-0.001502,-0.001309,-0.003418,-0.001509,-0.003011,-0.003151,-0.003425,-0.003011,-0.001509,-0.001583,-0.003425,-0.003839,-0.001502,-0.001583,-0.003137,-0.002190,-0.003285,-0.003425,-0.003285,-0.001509,-0.001309,-0.003425,-0.003285,-0.001502,-0.001583,-0.003972,-0.003285,-0.002190,-0.001916,-0.002190,-0.001509,-0.003151,-0.003285,-0.001583,-0.003839,-0.002744,-0.001502,-0.001775]},{w:"6",p:[0.468654,0.803429,0.472205,0.803429,0.472205,0.796454,0.468654,0.796454,-0.003551]},{w:"et al. ",p:[0.566656,0.803712,0.581510,0.803712,0.581510,0.796625,0.566656,0.796625,-0.003285,-0.001916,-0.001583,-0.003285,-0.001509,-0.001502,-0.001775]},{w:"Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, ",p:[0.581318,0.803359,0.940124,0.803359,0.940124,0.796625,0.581318,0.796625,-0.003425,-0.003285,-0.002190,-0.001509,-0.003285,-0.003425,-0.003285,-0.002190,-0.003358,-0.001916,-0.001509,-0.003003,-0.003285,-0.001583,-0.003425,-0.003011,-0.003285,-0.001583,-0.003285,-0.001916,-0.001583,-0.003285,-0.001916,-0.003285,-0.002190,-0.001509,-0.003151,-0.003285,-0.003003,-0.001509,-0.003425,-0.001583,-0.002190,-0.003285,-0.003425,-0.003425,-0.003151,-0.003285,-0.003011,-0.001583,-0.003425,-0.003285,-0.001509,-0.003425,-0.001583,-0.003285,-0.003425,-0.003425,-0.001583,-0.003285,-0.003425,-0.001509,-0.003285,-0.001509,-0.003425,-0.001583,-0.003011,-0.001509,-0.003425,-0.003285,-0.002604,-0.003285,-0.001916,-0.001916,-0.003285,-0.003151,-0.001916,-0.003011,-0.001583,-0.003285,-0.001916,-0.001916,-0.003285,-0.002190,-0.001583,-0.001916,-0.003285,-0.001916,-0.003285,-0.001509,-0.001583,-0.003285,-0.003425,-0.003425,-0.003285,-0.005341,-0.001509,-0.003425,-0.003285,-0.001509,-0.001583,-0.003425,-0.003003,-0.003011,-0.001916,-0.003285,-0.002190,-0.003285,-0.003151,-0.001916,-0.003285,-0.005341,-0.003003,-0.001502,-0.001583,-0.003285,-0.001583,-0.003425,-0.003285,-0.003425,-0.003425,-0.001509,-0.003285,-0.002604,-0.003425,-0.001509,-0.001509,-0.003425,-0.003425,-0.001502,-0.001583,-0.002190,-0.003285,-0.003425,-0.003425,-0.003285,-0.005304,-0.001509,-0.002878,-0.003285,-0.003425,-0.001502,-0.001775]},{w:"placebo-controlled phase III study. ",p:[0.080517,0.810275,0.175671,0.810275,0.175671,0.803541,0.080517,0.803541,-0.003425,-0.001509,-0.003285,-0.003151,-0.003285,-0.003425,-0.003285,-0.002604,-0.003151,-0.003285,-0.003425,-0.001916,-0.002190,-0.003285,-0.001509,-0.001509,-0.003285,-0.003425,-0.001842,-0.003425,-0.003425,-0.003285,-0.003011,-0.003285,-0.001842,-0.001509,-0.001509,-0.001509,-0.001842,-0.003011,-0.001916,-0.003425,-0.003499,-0.002596,-0.001502,-0.001775]},{w:"Curr Med Res Opin. ",p:[0.175747,0.810628,0.229698,0.810628,0.229698,0.803541,0.175747,0.803541,-0.003774,-0.003364,-0.002143,-0.002143,-0.001799,-0.005127,-0.003225,-0.003364,-0.001799,-0.003774,-0.003225,-0.002955,-0.001799,-0.004044,-0.003364,-0.001470,-0.003364,-0.001463,-0.001755]},{w:"2012;28(8):1323-1335.   . Bingham CO, Sebba AI, Rubin BR, ",p:[0.229742,0.810275,0.394703,0.810275,0.394703,0.803541,0.229742,0.803541,-0.003489,-0.003489,-0.003489,-0.003489,-0.001733,-0.003489,-0.003489,-0.001741,-0.003489,-0.001741,-0.001733,-0.003489,-0.003489,-0.003489,-0.003489,-0.002552,-0.003489,-0.003489,-0.003489,-0.003489,-0.001463,-0.001799,-0.001755,-0.003547,-0.001463,-0.001799,-0.003774,-0.001470,-0.003364,-0.003364,-0.003364,-0.003225,-0.005258,-0.001799,-0.003774,-0.004044,-0.001463,-0.001799,-0.003635,-0.003225,-0.003364,-0.003364,-0.003225,-0.001528,-0.003635,-0.001470,-0.001463,-0.001799,-0.003774,-0.003364,-0.003364,-0.001470,-0.003364,-0.001799,-0.003774,-0.003774,-0.001463,-0.001755]},{w:"7",p:[0.296631,0.810346,0.300141,0.810346,0.300141,0.803370,0.296631,0.803370,-0.003510]},{w:"et al.",p:[0.394747,0.810628,0.408094,0.810628,0.408094,0.803541,0.394747,0.803541,-0.003225,-0.001872,-0.001799,-0.003225,-0.001470,-0.001755]},{w:" Efﬁ  cacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. ",p:[0.408072,0.810275,0.898014,0.810275,0.898014,0.803541,0.408072,0.803541,-0.001799,-0.003364,-0.001872,-0.003386,0.001704,-0.001682,-0.003093,-0.003225,-0.002947,-0.002947,-0.001799,-0.003225,-0.003364,-0.003364,-0.001799,-0.002955,-0.003225,-0.001872,-0.003225,-0.001872,-0.002947,-0.001799,-0.003225,-0.001872,-0.001799,-0.003225,-0.001872,-0.003225,-0.002143,-0.001470,-0.003093,-0.003225,-0.002947,-0.001470,-0.003364,-0.001799,-0.003489,-0.003489,-0.001799,-0.005258,-0.003409,-0.001842,-0.003285,-0.003425,-0.003425,-0.001842,-0.003151,-0.003285,-0.001509,-0.003285,-0.003151,-0.003285,-0.003003,-0.001509,-0.003425,-0.001842,-0.003551,-0.003551,-0.003551,-0.001842,-0.005341,-0.003425,-0.001842,-0.001509,-0.003425,-0.001842,-0.001916,-0.003425,-0.003285,-0.001842,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.005341,-0.003285,-0.003425,-0.001916,-0.001842,-0.003285,-0.001916,-0.001842,-0.003285,-0.003011,-0.001916,-0.003285,-0.003285,-0.003285,-0.002190,-0.001916,-0.003425,-0.002190,-0.001509,-0.001916,-0.001509,-0.003011,-0.001842,-0.001509,-0.003425,-0.001842,-0.001916,-0.004794,-0.003285,-0.001842,-0.001509,-0.003425,-0.003285,-0.003425,-0.001916,-0.001509,-0.003151,-0.003285,-0.001509,-0.001509,-0.003003,-0.001842,-0.003425,-0.003285,-0.003011,-0.001509,-0.003425,-0.003425,-0.003285,-0.003425,-0.001502,-0.001842,-0.002190,-0.003285,-0.003425,-0.003425,-0.003285,-0.005341,-0.001509,-0.002878,-0.003285,-0.003425,-0.001502,-0.001842,-0.003425,-0.001509,-0.003285,-0.003151,-0.003285,-0.003425,-0.003285,-0.002604,-0.003151,-0.003285,-0.003425,-0.001916,-0.002190,-0.003285,-0.001509,-0.001509,-0.003285,-0.003425,-0.001502,-0.001842,-0.003425,-0.003285,-0.003425,-0.002604,-0.001509,-0.003425,-0.001916,-0.003285,-0.002234,-0.001509,-0.003285,-0.002190,-0.001509,-0.001916,-0.003003,-0.001842,-0.003011,-0.001916,-0.003425,-0.003425,-0.001509,-0.003285,-0.003011,-0.001502,-0.001775]},{w:"Rheumatology. ",p:[0.898088,0.810628,0.940128,0.810628,0.940128,0.803541,0.898088,0.803541,-0.003839,-0.003425,-0.003285,-0.003425,-0.005341,-0.003358,-0.001916,-0.003285,-0.001509,-0.003285,-0.003499,-0.002596,-0.001502,-0.001775]},{w:"2007;46:496–507.    Van der Heijde D, Baraf HSB, Ramos-Remus C, ",p:[0.080521,0.817191,0.271826,0.817191,0.271826,0.810457,0.080521,0.810457,-0.003551,-0.003551,-0.003551,-0.003551,-0.001775,-0.003551,-0.003551,-0.001775,-0.003551,-0.003551,-0.003551,-0.003699,-0.003551,-0.003551,-0.003551,-0.001494,-0.001849,-0.001775,-0.005408,-0.001576,-0.003285,-0.003285,-0.003425,-0.001849,-0.003425,-0.003285,-0.002190,-0.001849,-0.003972,-0.003285,-0.001509,-0.001509,-0.003425,-0.003285,-0.001849,-0.004113,-0.001502,-0.001849,-0.003839,-0.003285,-0.002190,-0.003285,-0.001916,-0.001849,-0.003972,-0.003699,-0.003839,-0.001502,-0.001849,-0.003839,-0.003285,-0.005341,-0.003285,-0.003011,-0.002604,-0.003839,-0.003285,-0.005341,-0.003425,-0.003011,-0.001849,-0.003839,-0.001502,-0.001775]},{w:"8.",p:[0.135580,0.817262,0.140906,0.817262,0.140906,0.810287,0.135580,0.810287,-0.003551,-0.001775]},{w:"et al. ",p:[0.271900,0.817544,0.287021,0.817544,0.287021,0.810457,0.271900,0.810457,-0.003285,-0.001916,-0.001849,-0.003285,-0.001509,-0.001502,-0.001775]},{w:"Evaluation of the Efﬁ  cacy of Etoricoxib in Ankylosing Spondylitis. ",p:[0.287095,0.817191,0.464257,0.817191,0.464257,0.810457,0.287095,0.810457,-0.003425,-0.003003,-0.003285,-0.001509,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001849,-0.003285,-0.001916,-0.001849,-0.001916,-0.003425,-0.003285,-0.001849,-0.003425,-0.001916,-0.003425,0.001716,-0.001709,-0.003151,-0.003285,-0.003003,-0.003003,-0.001849,-0.003285,-0.001916,-0.001849,-0.003425,-0.001916,-0.003285,-0.002190,-0.001509,-0.003151,-0.003285,-0.003003,-0.001509,-0.003425,-0.001849,-0.001509,-0.003425,-0.001576,-0.003699,-0.003425,-0.003285,-0.003003,-0.001509,-0.003285,-0.003011,-0.001509,-0.003425,-0.003425,-0.001849,-0.003699,-0.003425,-0.003285,-0.003425,-0.003499,-0.003003,-0.001509,-0.001509,-0.001916,-0.001509,-0.003011,-0.001502,-0.001775]},{w:"Arthritis \& Rheumatism. ",p:[0.464360,0.817544,0.531263,0.817544,0.531263,0.810457,0.464360,0.810457,-0.003699,-0.002190,-0.001916,-0.003425,-0.002190,-0.001509,-0.001916,-0.001509,-0.003011,-0.001849,-0.004113,-0.001849,-0.003839,-0.003425,-0.003285,-0.003425,-0.005341,-0.003358,-0.001916,-0.001509,-0.003011,-0.005341,-0.001502,-0.001775]},{w:"2005;52(4):1205-1215.   . Daniels SE, Bandy DP, Christensen SE, ",p:[0.531337,0.817191,0.712426,0.817191,0.712426,0.810457,0.531337,0.810457,-0.003551,-0.003551,-0.003551,-0.003551,-0.001775,-0.003551,-0.003551,-0.001783,-0.003551,-0.001783,-0.001775,-0.003551,-0.003551,-0.003551,-0.003551,-0.002604,-0.003551,-0.003551,-0.003551,-0.003551,-0.001494,-0.001849,-0.001775,-0.003639,-0.001502,-0.001849,-0.004113,-0.003285,-0.003425,-0.001509,-0.003285,-0.001509,-0.003011,-0.001849,-0.003699,-0.003425,-0.001502,-0.001849,-0.003839,-0.003285,-0.003425,-0.003499,-0.003003,-0.001849,-0.004113,-0.002604,-0.001502,-0.001849,-0.003839,-0.003425,-0.002190,-0.001509,-0.003011,-0.001916,-0.003285,-0.003425,-0.003011,-0.003285,-0.003425,-0.001849,-0.003699,-0.003425,-0.001502,-0.001775]},{w:"9",p:[0.599527,0.817262,0.603077,0.817262,0.603077,0.810287,0.599527,0.810287,-0.003551]},{w:"et al.",p:[0.712500,0.817544,0.726119,0.817544,0.726119,0.810457,0.712500,0.810457,-0.003285,-0.001916,-0.001849,-0.003285,-0.001509,-0.001775]},{w:" Evaluation of the Dose Range of Etoricoxib in an Acute Pain Setting Using the ",p:[0.726119,0.817191,0.940098,0.817191,0.940098,0.810457,0.726119,0.810457,-0.001849,-0.003425,-0.003003,-0.003285,-0.001509,-0.003425,-0.003358,-0.001916,-0.001509,-0.003285,-0.003425,-0.001849,-0.003285,-0.001916,-0.001849,-0.001916,-0.003425,-0.003285,-0.001849,-0.004113,-0.003285,-0.003011,-0.003285,-0.001849,-0.003839,-0.003285,-0.003425,-0.003425,-0.003285,-0.001849,-0.003285,-0.001916,-0.001849,-0.003425,-0.001916,-0.003285,-0.002190,-0.001509,-0.003151,-0.003285,-0.003003,-0.001509,-0.003425,-0.001849,-0.001509,-0.003425,-0.001849,-0.003285,-0.003425,-0.001576,-0.003699,-0.003151,-0.003425,-0.001916,-0.003285,-0.001849,-0.003425,-0.003285,-0.001509,-0.003425,-0.001849,-0.003699,-0.003285,-0.001916,-0.001916,-0.001509,-0.003425,-0.003425,-0.001849,-0.003839,-0.003011,-0.001509,-0.003425,-0.003425,-0.001849,-0.001916,-0.003425,-0.003285,-0.001775]},{w:"Postoperative Dental Pain Model. ",p:[0.080521,0.824108,0.171902,0.824108,0.171902,0.817374,0.080521,0.817374,-0.003425,-0.003285,-0.003011,-0.001916,-0.003285,-0.003425,-0.003285,-0.002190,-0.003358,-0.001916,-0.001509,-0.003003,-0.003285,-0.001775,-0.004113,-0.003285,-0.003425,-0.001916,-0.003285,-0.001509,-0.001775,-0.003425,-0.003285,-0.001509,-0.003425,-0.001775,-0.005208,-0.003285,-0.003425,-0.003285,-0.001509,-0.001502,-0.001775]},{w:"Clin J Pain. ",p:[0.171902,0.824461,0.203807,0.824461,0.203807,0.817374,0.171902,0.817374,-0.003839,-0.001509,-0.001509,-0.003425,-0.001775,-0.003151,-0.001775,-0.003425,-0.003285,-0.001509,-0.003425,-0.001502,-0.001775]},{w:"2011;27(1):1–8.   . Matsumoto AK, Melian A, Mandel DR, ",p:[0.203807,0.824108,0.364768,0.824108,0.364768,0.817374,0.203807,0.817374,-0.003551,-0.003551,-0.003551,-0.003551,-0.001775,-0.003551,-0.003551,-0.001783,-0.003551,-0.001783,-0.001775,-0.003551,-0.003699,-0.003551,-0.001502,-0.001775,-0.001775,-0.007102,-0.001502,-0.001775,-0.005208,-0.003358,-0.001916,-0.003011,-0.003425,-0.005341,-0.003285,-0.001916,-0.003285,-0.001502,-0.003699,-0.003699,-0.001502,-0.001775,-0.005208,-0.003285,-0.001509,-0.001509,-0.003285,-0.003425,-0.001502,-0.003699,-0.001502,-0.001775,-0.005208,-0.003285,-0.003425,-0.003425,-0.003285,-0.001509,-0.001775,-0.004113,-0.003839,-0.001502,-0.001775]},{w:"10",p:[0.251631,0.824178,0.258733,0.824178,0.258733,0.817203,0.251631,0.817203,-0.003551,-0.003551]},{w:"et al. ",p:[0.364768,0.824461,0.379815,0.824461,0.379815,0.817374,0.364768,0.817374,-0.003285,-0.001916,-0.001775,-0.003285,-0.001509,-0.001502,-0.001775]},{w:"for Etoricoxib Rheumatoid Arthritis Study Group. A randomised, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.",p:[0.379815,0.824108,0.759016,0.824108,0.759016,0.817374,0.379815,0.817374,-0.001916,-0.003285,-0.002190,-0.001775,-0.003425,-0.001916,-0.003285,-0.002190,-0.001509,-0.003151,-0.003285,-0.003003,-0.001509,-0.003425,-0.001775,-0.003839,-0.003425,-0.003285,-0.003425,-0.005341,-0.003351,-0.001916,-0.003285,-0.001509,-0.003425,-0.001502,-0.003699,-0.002190,-0.001916,-0.003425,-0.002190,-0.001509,-0.001916,-0.001509,-0.003011,-0.001775,-0.003699,-0.001916,-0.003425,-0.003499,-0.003003,-0.001775,-0.003972,-0.002190,-0.003285,-0.003425,-0.003425,-0.001502,-0.001502,-0.003699,-0.001775,-0.002190,-0.003285,-0.003425,-0.003425,-0.003285,-0.005341,-0.001509,-0.003011,-0.003285,-0.003425,-0.001502,-0.001775,-0.003151,-0.003285,-0.003425,-0.001916,-0.002190,-0.003285,-0.001509,-0.001509,-0.003285,-0.003425,-0.001502,-0.001775,-0.003003,-0.001509,-0.001509,-0.003425,-0.001509,-0.003151,-0.003285,-0.001509,-0.001775,-0.001916,-0.002190,-0.001509,-0.003285,-0.001509,-0.001775,-0.003285,-0.001916,-0.001775,-0.003285,-0.001916,-0.003285,-0.002190,-0.001509,-0.003151,-0.003285,-0.003003,-0.001509,-0.003425,-0.001775,-0.001509,-0.003425,-0.001775,-0.001916,-0.003425,-0.003285,-0.001775,-0.001916,-0.002190,-0.003285,-0.003358,-0.001916,-0.005341,-0.003285,-0.003425,-0.001916,-0.001775,-0.003285,-0.001916,-0.001775,-0.002190,-0.003425,-0.003285,-0.003425,-0.005341,-0.003358,-0.001916,-0.003285,-0.001509,-0.003425,-0.001775,-0.003285,-0.002190,-0.001916,-0.003425,-0.002190,-0.001509,-0.001916,-0.001509,-0.003011,-0.001775]},{w:" J Rheumatol. ",p:[0.759016,0.824461,0.798378,0.824461,0.798378,0.817374,0.759016,0.817374,-0.001775,-0.003151,-0.001775,-0.003839,-0.003425,-0.003285,-0.003425,-0.005341,-0.003358,-0.001916,-0.003285,-0.001509,-0.001502,-0.001775]},{w:"2002;29(8):1623–1630.",p:[0.798378,0.824108,0.864230,0.824108,0.864230,0.817374,0.798378,0.817374,-0.003551,-0.003551,-0.003551,-0.003551,-0.001775,-0.003551,-0.003551,-0.001783,-0.003551,-0.001783,-0.001775,-0.003551,-0.003551,-0.003551,-0.003551,-0.003699,-0.003551,-0.003551,-0.003551,-0.003551,-0.001775]},{w:"For full prescribing information refer to the package insert",p:[0.635802,0.941868,0.938353,0.941868,0.938353,0.931126,0.635802,0.931126,-0.005994,-0.006214,-0.004311,-0.003418,-0.003832,-0.006473,-0.003107,-0.003107,-0.003418,-0.006473,-0.004311,-0.005994,-0.005748,-0.005994,-0.004311,-0.003107,-0.006473,-0.003107,-0.006473,-0.006473,-0.003418,-0.003107,-0.006473,-0.003832,-0.006214,-0.004311,-0.009813,-0.006227,-0.003832,-0.003107,-0.006214,-0.006473,-0.003418,-0.004311,-0.005994,-0.003832,-0.005994,-0.004311,-0.003418,-0.003832,-0.006214,-0.003418,-0.003832,-0.006473,-0.005994,-0.003418,-0.006473,-0.006227,-0.005994,-0.006473,-0.006227,-0.006473,-0.005994,-0.003418,-0.003107,-0.006473,-0.005748,-0.005994,-0.004311,-0.003832]},{w:"approved by the Medicines Regulatory Authority.",p:[0.687326,0.953199,0.938832,0.953199,0.938832,0.942457,0.687326,0.942457,-0.006227,-0.006473,-0.006473,-0.004311,-0.006343,-0.005748,-0.005994,-0.006473,-0.003418,-0.006473,-0.005748,-0.003418,-0.003832,-0.006473,-0.005994,-0.003418,-0.009580,-0.005994,-0.006473,-0.003107,-0.005994,-0.003107,-0.006473,-0.005994,-0.005748,-0.003418,-0.007198,-0.005994,-0.006473,-0.006473,-0.003107,-0.006227,-0.003832,-0.006214,-0.004544,-0.005748,-0.003418,-0.007198,-0.006473,-0.003832,-0.006473,-0.006214,-0.004311,-0.003107,-0.003832,-0.005036,-0.003107]},{w:"MSD (Pty) Ltd (Reg. No. 1996/003791/07),",p:[0.193116,0.942348,0.395377,0.942348,0.395377,0.931978,0.193116,0.931978,-0.009114,-0.006473,-0.007198,-0.003107,-0.003120,-0.006227,-0.003353,-0.005256,-0.003120,-0.003107,-0.005748,-0.003353,-0.005994,-0.003107,-0.003120,-0.006719,-0.005748,-0.005994,-0.002628,-0.003107,-0.007198,-0.005748,-0.002628,-0.003107,-0.006214,-0.006214,-0.006214,-0.006214,-0.003599,-0.006214,-0.006214,-0.006214,-0.006214,-0.006214,-0.006214,-0.003599,-0.006214,-0.006214,-0.003120,-0.003107]},{w:"Private Bag 3, Halfway House, 1685. Tel: 011 655 3000. www.msd.co.za",p:[0.193116,0.953679,0.539461,0.953679,0.539461,0.943309,0.193116,0.943309,-0.006227,-0.003832,-0.002641,-0.005256,-0.005877,-0.003353,-0.005748,-0.003107,-0.006719,-0.005877,-0.005994,-0.003107,-0.006214,-0.002628,-0.003107,-0.006952,-0.005748,-0.002641,-0.003353,-0.008389,-0.005748,-0.005256,-0.003107,-0.006952,-0.005748,-0.005994,-0.005269,-0.005748,-0.002628,-0.003107,-0.006214,-0.006214,-0.006214,-0.006214,-0.002628,-0.002628,-0.005036,-0.005748,-0.002641,-0.002628,-0.003107,-0.006214,-0.006214,-0.006214,-0.003107,-0.006214,-0.006214,-0.006214,-0.003107,-0.006214,-0.006214,-0.006214,-0.006214,-0.002628,-0.003107,-0.008389,-0.008389,-0.007910,-0.003107,-0.009347,-0.005269,-0.005994,-0.003107,-0.005515,-0.005748,-0.003107,-0.005036,-0.005748]},{w:"S3 ",p:[0.081827,0.965264,0.093163,0.965264,0.093163,0.957746,0.081827,0.957746,-0.004646,-0.004460,-0.002230]},{w:"EXINEF",p:[0.096722,0.965343,0.122683,0.965343,0.122683,0.957555,0.096722,0.957555,-0.004469,-0.004990,-0.002397,-0.005333,-0.004469,-0.004302]},{w:" – Reg. No’s: 30 mg – 44/3.1/0898, 60 mg – 44/3.1/0899, 90 mg – 44/3.1/0900, 120 mg – 44/3.1/0901. Each EXINEF tablet contains 30 mg, 60 mg, 90 mg or 120 mg of etoricoxib.  S3 ",p:[0.122683,0.965264,0.776067,0.965264,0.776067,0.957746,0.122683,0.957746,-0.002602,-0.004646,-0.002602,-0.004822,-0.004126,-0.004302,-0.002230,-0.002602,-0.005166,-0.004126,-0.002230,-0.003782,-0.002230,-0.002602,-0.004460,-0.004460,-0.002602,-0.006709,-0.004302,-0.002602,-0.004646,-0.002602,-0.004460,-0.004460,-0.002583,-0.004460,-0.002230,-0.004460,-0.002583,-0.004460,-0.004460,-0.004460,-0.004460,-0.002230,-0.002602,-0.004460,-0.004460,-0.002602,-0.006709,-0.004302,-0.002602,-0.004646,-0.002602,-0.004460,-0.004460,-0.002583,-0.004460,-0.002230,-0.004460,-0.002583,-0.004460,-0.004460,-0.004460,-0.004460,-0.002230,-0.002602,-0.004460,-0.004460,-0.002602,-0.006709,-0.004302,-0.002602,-0.004646,-0.002602,-0.004460,-0.004460,-0.002583,-0.004460,-0.002230,-0.004460,-0.002583,-0.004460,-0.004460,-0.004460,-0.004460,-0.002230,-0.002602,-0.004460,-0.004460,-0.004460,-0.002602,-0.006709,-0.004302,-0.002602,-0.004646,-0.002602,-0.004460,-0.004460,-0.002583,-0.004460,-0.002230,-0.004460,-0.002583,-0.004460,-0.004460,-0.004460,-0.004460,-0.002230,-0.002602,-0.004302,-0.004126,-0.003958,-0.004302,-0.002602,-0.004302,-0.004469,-0.001895,-0.005166,-0.004302,-0.004126,-0.002602,-0.002406,-0.004126,-0.004302,-0.001895,-0.004126,-0.002406,-0.002602,-0.003958,-0.004126,-0.004302,-0.002406,-0.004126,-0.001895,-0.004302,-0.003782,-0.002602,-0.004460,-0.004460,-0.002602,-0.006709,-0.004302,-0.002230,-0.002602,-0.004460,-0.004460,-0.002602,-0.006709,-0.004302,-0.002230,-0.002602,-0.004460,-0.004460,-0.002602,-0.006709,-0.004302,-0.002602,-0.004126,-0.002750,-0.002602,-0.004460,-0.004460,-0.004460,-0.002602,-0.006709,-0.004302,-0.002602,-0.004126,-0.002406,-0.002602,-0.004126,-0.002406,-0.004126,-0.002750,-0.001895,-0.003958,-0.004126,-0.003772,-0.001895,-0.004302,-0.002230,-0.002602,-0.002602,-0.004646,-0.004460,-0.002230]},{w:"ARCOXIA",p:[0.779003,0.965343,0.812044,0.965343,0.812044,0.957555,0.779003,0.957555,-0.005166,-0.005166,-0.004990,-0.005166,-0.004990,-0.002397,-0.005166]},{w:" – Reg. No’s: 30 mg – 44/3.1/0063,",p:[0.812044,0.965264,0.937796,0.965264,0.937796,0.957746,0.812044,0.957746,-0.002602,-0.004646,-0.002602,-0.004822,-0.004126,-0.004302,-0.002230,-0.002602,-0.005166,-0.004126,-0.002230,-0.003782,-0.002230,-0.002602,-0.004460,-0.004460,-0.002602,-0.006709,-0.004302,-0.002602,-0.004646,-0.002602,-0.004460,-0.004460,-0.002583,-0.004460,-0.002230,-0.004460,-0.002583,-0.004460,-0.004460,-0.004460,-0.004460,-0.002230]},{w:"60 mg – 37/3.1/0399, 90 mg – 37/3.1/0400, 120 mg – 37/3.1/0401. Each ARCOXIA tablet contains 30 mg, 60 mg, 90 mg or 120 mg of etoricoxib. Copyright © 2019 Merck Sharp \& Dohme Corp., a subsidiary of Merck \& Co., Inc., Kenilworth,",p:[0.081818,0.973420,0.938057,0.973420,0.938057,0.965901,0.081818,0.965901,-0.004460,-0.004460,-0.002890,-0.006709,-0.004302,-0.002890,-0.004646,-0.002890,-0.004460,-0.004460,-0.002583,-0.004460,-0.002230,-0.004460,-0.002583,-0.004460,-0.004460,-0.004460,-0.004460,-0.002230,-0.002890,-0.004460,-0.004460,-0.002890,-0.006709,-0.004302,-0.002890,-0.004646,-0.002890,-0.004460,-0.004460,-0.002583,-0.004460,-0.002230,-0.004460,-0.002583,-0.004460,-0.004460,-0.004460,-0.004460,-0.002230,-0.002890,-0.004460,-0.004460,-0.004460,-0.002890,-0.006709,-0.004302,-0.002890,-0.004646,-0.002890,-0.004460,-0.004460,-0.002583,-0.004460,-0.002230,-0.004460,-0.002583,-0.004460,-0.004460,-0.004460,-0.004460,-0.002230,-0.002890,-0.004302,-0.004126,-0.003958,-0.004302,-0.002890,-0.004646,-0.004822,-0.004822,-0.005166,-0.004469,-0.001895,-0.004646,-0.002890,-0.002406,-0.004126,-0.004302,-0.001895,-0.004126,-0.002406,-0.002890,-0.003958,-0.004126,-0.004302,-0.002406,-0.004126,-0.001895,-0.004302,-0.003782,-0.002890,-0.004460,-0.004460,-0.002890,-0.006709,-0.004302,-0.002230,-0.002890,-0.004460,-0.004460,-0.002890,-0.006709,-0.004302,-0.002230,-0.002890,-0.004460,-0.004460,-0.002890,-0.006709,-0.004302,-0.002890,-0.004126,-0.002750,-0.002890,-0.004460,-0.004460,-0.004460,-0.002890,-0.006709,-0.004302,-0.002890,-0.004126,-0.002406,-0.002890,-0.004126,-0.002406,-0.004126,-0.002750,-0.001895,-0.003958,-0.004126,-0.003772,-0.001895,-0.004302,-0.002230,-0.002890,-0.004822,-0.004126,-0.004302,-0.003772,-0.002750,-0.001895,-0.004302,-0.004302,-0.002406,-0.002890,-0.007433,-0.002890,-0.004460,-0.004460,-0.004460,-0.004460,-0.002890,-0.006541,-0.004126,-0.002750,-0.003958,-0.004126,-0.002890,-0.004646,-0.004302,-0.004126,-0.002750,-0.004302,-0.002890,-0.005166,-0.002890,-0.005166,-0.004126,-0.004302,-0.006709,-0.004126,-0.002890,-0.004822,-0.004126,-0.002750,-0.004302,-0.002230,-0.001886,-0.002890,-0.004126,-0.002890,-0.003782,-0.004302,-0.004302,-0.003782,-0.001895,-0.004302,-0.001895,-0.004126,-0.002918,-0.003772,-0.002890,-0.004126,-0.002406,-0.002890,-0.006541,-0.004126,-0.002750,-0.003958,-0.004126,-0.002890,-0.005166,-0.002890,-0.004822,-0.004126,-0.002230,-0.001886,-0.002890,-0.001895,-0.004302,-0.003958,-0.002230,-0.001886,-0.002890,-0.004646,-0.004126,-0.004302,-0.001895,-0.001988,-0.006021,-0.004126,-0.002750,-0.002406,-0.004302,-0.002230]},{w:"NJ, USA. All rights reserved. ZA-CXB-00008 04/21",p:[0.081818,0.981576,0.255190,0.981576,0.255190,0.974057,0.081818,0.974057,-0.005166,-0.003958,-0.001886,-0.002453,-0.004822,-0.004646,-0.004646,-0.001886,-0.002109,-0.004646,-0.001895,-0.001895,-0.002453,-0.002750,-0.001895,-0.004302,-0.004302,-0.002406,-0.003782,-0.002453,-0.002750,-0.004126,-0.003782,-0.004126,-0.002918,-0.003772,-0.004126,-0.004302,-0.001886,-0.002453,-0.004302,-0.004646,-0.003271,-0.004822,-0.004469,-0.004822,-0.003271,-0.004460,-0.004460,-0.004460,-0.004460,-0.004460,-0.002453,-0.004460,-0.004460,-0.002583,-0.004460,-0.004460]},{w:"   ",p:[0.255190,0.981523,0.262326,0.981523,0.262326,0.974090,0.255190,0.974090,-0.002453,-0.002453,-0.002230]},{w:"Two select indices listing products by:",p:[0.110028,0.216565,0.826574,0.216565,0.826574,0.184806,0.110028,0.184806,-0.013757,-0.030316,-0.025702,-0.011902,-0.016344,-0.025788,-0.008668,-0.025788,-0.025702,-0.011428,-0.011902,-0.008668,-0.024322,-0.027341,-0.008668,-0.025702,-0.025788,-0.016344,-0.011902,-0.008668,-0.008668,-0.016344,-0.011428,-0.008668,-0.024322,-0.027341,-0.011902,-0.027341,-0.012032,-0.025702,-0.027341,-0.023934,-0.025702,-0.011428,-0.016344,-0.011902,-0.027341,-0.021648,-0.012463]},{w:"ü",p:[0.342633,0.241770,0.372762,0.241770,0.372762,0.215635,0.342633,0.215635,-0.030129]},{w:" Trade Name",p:[0.372379,0.242359,0.594016,0.242359,0.594016,0.214129,0.372379,0.214129,-0.010580,-0.012228,-0.010695,-0.024303,-0.024303,-0.022923,-0.010580,-0.025529,-0.024303,-0.032889,-0.023306]},{w:"ü",p:[0.302959,0.268259,0.333088,0.268259,0.333088,0.242124,0.302959,0.242124,-0.030129]},{w:" Active Ingredient",p:[0.332705,0.268847,0.633729,0.268847,0.633729,0.240617,0.332705,0.240617,-0.010580,-0.022693,-0.022846,-0.010158,-0.007705,-0.018591,-0.022923,-0.010580,-0.008318,-0.021619,-0.024303,-0.010695,-0.022923,-0.024303,-0.007705,-0.022923,-0.021619,-0.010541]},{w:"INDICES",p:[0.500771,0.162705,0.953042,0.162705,0.953042,0.055076,0.500771,0.055076,-0.029100,-0.086660,-0.086660,-0.029100,-0.096402,-0.063456,-0.060892]},{w:"April 2020",p:[0.794479,0.033994,0.943677,0.033994,0.943677,0.009293,0.794479,0.009293,-0.019477,-0.020713,-0.010268,-0.007973,-0.007973,-0.010180,-0.018595,-0.018595,-0.018595,-0.016829]},{w:"Volume 60 Number 4",p:[0.075677,0.033994,0.387959,0.033994,0.387959,0.009293,0.075677,0.009293,-0.016829,-0.019595,-0.007973,-0.018389,-0.027303,-0.019654,-0.010180,-0.018595,-0.018595,-0.010180,-0.021654,-0.018389,-0.027303,-0.020713,-0.019654,-0.010268,-0.010180,-0.016829]}]};